2024 Summer Conference | P2 - Poster Session 02

Date Friday 07/19/24

Time 02:45 PM - 03:45 PM EDT Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Scientific Poster Session

Topic(s) Aging, Dementia, and Behavioral Neurology, Autoimmune Neurology, General Neurology, Global Health and Neuroepidemiology, Infectious Disease, Multiple Sclerosis, Neuro-oncology, Neuromuscular and Clinical Neurophysiology (EMG)

Learning Objectives Participants will view the latest research on autoimmune neurology. Posters are available in-person or online.

CME Available 0.00 CME credit

Core Competencies Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement, Systems-based Practice

Program Tracks Neurohospitalist

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student, Business Administrator

Teaching Styles Interactive

Event Timeline
02:45 PM - 03:45 PM EDT	Abstract	002 - Atypical Case of Prion Disease with D178N-homozygous 129M Genotype Thanapoom Taweephol, MD
02:45 PM - 03:45 PM EDT	Abstract	003 - Comparative Effectiveness and Safety of Disease-modifying Treatments (DMTs) in a Real-World Neuromyelitis Optica Spectrum Disorder Cohort (NMOSD) Philippe-Antoine Bilodeau, MD
02:45 PM - 03:45 PM EDT	Abstract	004 - Efficacy and Safety of Ravulizumab in Adults With Anti-Aquaporin-4 Antibody-Positive (AQP4-Ab+) Neuromyelitis Optica Spectrum Disorder (NMOSD): Interim Analysis From the Ongoing Phase 3 CHAMPION-NMOSD Trial Sean J. Pittock, MD, FAAN
02:45 PM - 03:45 PM EDT	Abstract	005 - Evaluation of Glial Fibrillary Acidic Protein (GFAP) and Neurofilament Light Chain (NfL) Levels During Eculizumab and Ravulizumab Treatments in Anti-Aquaporin-4-Positive (AQP4-Ab+) Neuromyelitis Optica Spectrum Disorder (NMOSD) Sean Kearns, PhD
02:45 PM - 03:45 PM EDT	Abstract	006 - Incidence of Relapses After Meningococcal Vaccination in Clinical Trials of Eculizumab and Ravulizumab in Anti-Aquaporin-4 Antibody-Positive (AQP4-Ab+) Neuromyelitis Optica Spectrum Disorder (NMOSD) Josin James, PharmD, RPh
02:45 PM - 03:45 PM EDT	Abstract	007 - Socioeconomic Factors Associated with ≥2-year Delayed Diagnosis of Neuromyelitis Optica Spectrum Disorder (NMOSD) in the United States Michael Blackowicz, PhD
02:45 PM - 03:45 PM EDT	Abstract	008 - Frequency and Phenotype of Aquaporin-4-IgG and Coexistent Autoimmune Encephalitis Antibody Biomarkers Laura Cacciaguerra, MD, PhD
02:45 PM - 03:45 PM EDT	Abstract	009 - NMOSD: Previously Seropositive Patient Presents with Seronegative Brainstem Attack Drew Weber, MD
02:45 PM - 03:45 PM EDT	Abstract	010 - Cerebellar Involvement During Attacks of Aquaporin-4-IgG Positive Neuromyelitis Optica Spectrum Disorder Alessandro Dinoto, MD
02:45 PM - 03:45 PM EDT	Abstract	011 - Safety Findings in Patients With Anti-Aquaporin-4-Antibody-Positive (AQP4-Ab+) Neuromyelitis Optica Spectrum Disorder (NMOSD) Who Received Eculizumab or Ravulizumab in the PREVENT and CHAMPION-NMOSD Studies and Had Received Rituximab Within 1 Year Prior to Enrollment Michael Levy, MD, PhD, FAAN
02:45 PM - 03:45 PM EDT	Abstract	013 - Preferences for Treatment Features for Neuromyelitis Optica Spectrum Disorder (NMOSD): Results From a Discrete Choice Experiment Study Justin Abbatemarco, MD
02:45 PM - 03:45 PM EDT	Abstract	014 - Risk Factors Influencing Relapse Rate in Double Seronegative Neuromyelitis Optica Spectrum Disorder (DSNMOSD): A Multicenter Study Gerome B. Vallejos, MD
02:45 PM - 03:45 PM EDT	Abstract	015 - A Global, Long-Term, Prospective, Observational Registry of Patients With Anti-Aquaporin-4 Antibody-Positive (AQP4-Ab+) Neuromyelitis Optica Spectrum Disorder (NMOSD) Treated With Complement Component 5 Inhibitor Therapies (C5ITs) Eculizumab or Ravulizumab Ukwen Akpoji, PharmD
02:45 PM - 03:45 PM EDT	Abstract	016 - A Case of Neuromyelitis Optica Spectrum Disorder/Systemic Lupus Erythematosus Overlap Syndrome Initially Misdiagnosed as Bacterial Meningitis Danah Bakir, MD
02:45 PM - 03:45 PM EDT	Abstract	017 - Neuromyelitis Optica Spectrum Disorder (NMOSD) in a Patient with Noonan Syndrome and Prior Juvenile Myelomonocytic Leukemia Madeleine H. McLaughlin, MD
02:45 PM - 03:45 PM EDT	Abstract	018 - Anti-Yo Positive Paraneoplastic Cerebellar Degeneration: A Systematic Review of Cases Gerardo M. Luna-Peralta
02:45 PM - 03:45 PM EDT	Abstract	019 - Goals and Design of a Dedicated Tertiary Care Centre NMOSD/MOGAD Clinic Jodie Burton, MD, FAAN
02:45 PM - 03:45 PM EDT	Abstract	021 - May Steroids Wake You Up! A Rare Case of Diencephalic Syndrome of Neuromyelitis Optica Spectrum Disorder Gowri Anil Peethambar, MBBS
02:45 PM - 03:45 PM EDT	Abstract	022 - Paraneoplastic Neuromyelitis Optica Associated with Renal Cell Carcinoma Presenting with Tumefactive Demyelination Lesions Alexander Carvajal- Gonzalez, MD, PhD
02:45 PM - 03:45 PM EDT	Abstract	023 - NMODS Secondary to Pembrolizumab Therapy: A Case Report Syed A. Hussain, MD
02:45 PM - 03:45 PM EDT	Abstract	024 - Post-Traumatic NMOSD Myelopathy in Octogenarians Allyson Hamacher, PA
02:45 PM - 03:45 PM EDT	Abstract	025 - Neuromyelitis Optica Spectrum Disorder with Overlapping Lupus Cerebritis: A Case Report Samantha Plum, MD
02:45 PM - 03:45 PM EDT	Abstract	026 - Further Investigation of the Unclear Role of Aquaporin-4 Antibodies in HIV Infection Associated Neuromyelitis Optica Spectrum Disorder Joshua Currie
02:45 PM - 03:45 PM EDT	Abstract	027 - Seeing Through the Blurry Vision of MOGAD vs NMOSD Deeksha Barman, MBBS
02:45 PM - 03:45 PM EDT	Abstract	028 - SLIPPERS Syndrome: Clinical Heterogeneity and Management Challenges in Two Case Studies Kian Fahimdanesh, Medical Student
02:45 PM - 03:45 PM EDT	Abstract	029 - Efficacy and Safety of Efgartigimod PH20 in Chronic Inflammatory Demyelinating Polyneuropathy: Results of ADHERE/ADHERE+ Niraja S. Suresh, MD
02:45 PM - 03:45 PM EDT	Abstract	030 - Intrathecal Steroids: A More Targeted Approach to Central Nervous System Inflammation Kristen Fisher, DO
02:45 PM - 03:45 PM EDT	Abstract	031 - Ultra-Rapid Progressive Dementia: Characteristics of an Uncommon Neurological Disorder Yoav Piura, MD
02:45 PM - 03:45 PM EDT	Abstract	032 - A Pilot’s Pilot- Narcolepsy Following SARS-CoV-2 Infection Cristah Prost, MD
02:45 PM - 03:45 PM EDT	Abstract	032 - Consensus Recommendations for the Management of Neurosarcoidosis: A Delphi Survey of Experts Across the US Giovanna Manzano, MD
02:45 PM - 03:45 PM EDT	Abstract	033 - Evaluation of the Performance of the EUROIMMUN Anti-GABAA Receptor IFA in Patients with Suspected Autoimmune Anti-GABAAR Encephalitis Maite Sabalza
02:45 PM - 03:45 PM EDT	Abstract	034 - High-grade Glioma in a Patient with Known Stage 4 Renal Cell Carcinoma: Pitfalls in Diagnosis Vanessa E. Chicas
02:45 PM - 03:45 PM EDT	Abstract	035 - Acute Disseminated Encephalomyelitis in the Setting of Systemic Epstein-Barr Virus Post-Transplant Lymphoproliferative Disease: A Rare Presentation with a Broad Differential Safa Kaleem, MD
02:45 PM - 03:45 PM EDT	Abstract	036 - A Rare Case Report of Miller Fisher Syndrome Overlapping with Myasthenia Gravis Matthew He
02:45 PM - 03:45 PM EDT	Abstract	037 - Is It a Lupus Flare? Anti-GAD65 Limbic Encephalitis Presenting With Psychosis in a Patient With Systemic Lupus Erythematosus Byron D. Cheon, MD
02:45 PM - 03:45 PM EDT	Abstract	038 - Mononeuritis Multiplex Due to Medium Vessel Vasculitis Diagnosed via PET CT: A Case Report Aimen Vanood, MD
02:45 PM - 03:45 PM EDT	Abstract	039 - Vogt-Koyanagi-Harada Syndrome: A COVID Sequela? Tiffany A. Eatz, MD
02:45 PM - 03:45 PM EDT	Abstract	040 - Autoimmune Encephalitis with Hemorrhagic CSF Abhilash Thatikala, MD, MBBS, DM
02:45 PM - 03:45 PM EDT	Abstract	041 - Atypical Presentation of Chronic Inflammatory Demyelinating Polyneuropathy and Comorbid Psychiatric Disorders Seema Arshed
02:45 PM - 03:45 PM EDT	Abstract	042 - Post-viral Induced Optic Perineuritis Pooja Patel, DO
02:45 PM - 03:45 PM EDT	Abstract	043 - Not One-in-a-million: A Single-Center Case Series of Patients with Stiff Person Syndrome Paul D. Crane, MD
02:45 PM - 03:45 PM EDT	Abstract	044 - The Risk of Epilepsy in Systemic Autoimmune Diseases: A Population-based Study in Olmsted County, Minnesota Shemonti Hasan, MD
02:45 PM - 03:45 PM EDT	Abstract	045 - Epidemiology of Seropositive Neuromyelitis Optica Spectrum Disorder in a Large US Population Barrie L. Zerwic, MD
02:45 PM - 03:45 PM EDT	Abstract	046 - Trends in Mortality Among Patients With Guillain-Barré Syndrome from 1999 to 2020: A Retrospective Study in the United States Suhrud Panchawagh, MBBS
02:45 PM - 03:45 PM EDT	Abstract	047 - A Retrospective CDC WONDER Analysis of Demographic Trends in Myasthenia Gravis-Related Mortality Rates in the US from 1999-2020 Fnu Javairia
02:45 PM - 03:45 PM EDT	Abstract	048 - Extensive Reactive Myelitis Secondary to Long-standing Cervical Spinal Hardware Jissmaria Karickal
02:45 PM - 03:45 PM EDT	Abstract	049 - From Lacrimal Sarcoid to Status Epilepticus: A Pathway Through the Sinuses Gabriela Mata, MD
02:45 PM - 03:45 PM EDT	Abstract	050 - A Pharmacovigilance Study of FDA Approved Medications for Neuromyelitis Optica Spectrum Disorder (NMOSD) Jaahnavee Trivedi, MD
02:45 PM - 03:45 PM EDT	Abstract	051 - Powassan Virus Encephalitis in Pediatric Patients: A Case Series Celia Greenlaw, MD
02:45 PM - 03:45 PM EDT	Abstract	052 - Cryptococcal Meningitis in HIV: A Comparative Study Between Asymptomatic and Symptomatic Cases and Mortality Parameters Bhavya Jaya Venugopal, MD
02:45 PM - 03:45 PM EDT	Abstract	053 - Neuroinvasive West Nile Virus Associated with Anti-CD20 Therapies in a University Health System Rumyar V. Ardakani, MD
02:45 PM - 03:45 PM EDT	Abstract	054 - Unveiling the Spectrum: Investigating HIV-Associated Neurological Challenges in Hospitalized Patients and Predicting Prognosis Over Three Months Mamadou Diallo, MD
02:45 PM - 03:45 PM EDT	Abstract	055 - FACE DROP: A Clinical Risk Assessment Tool to Differentiate Acute Lyme Disease Facial Palsy From Bell’s Palsy Caleb R. McEntire, MD
02:45 PM - 03:45 PM EDT	Abstract	056 - Neurologic and Psychiatric Symptoms of Long COVID in a Pediatric Neurology Clinic Margaret M. Wilson-Murphy, MD
02:45 PM - 03:45 PM EDT	Abstract	057 - Mycobacterium celatum Encephalitis in an Immunocompromised Host Mimicking Autoimmune Encephalitis: The First Case Report Thanapoom Taweephol, MD
02:45 PM - 03:45 PM EDT	Abstract	058 - Neurological Manifestations of Leptospirosis: A Retrospective Study from India Bhavya Jaya Venugopal, MD
02:45 PM - 03:45 PM EDT	Abstract	059 - To Describe an Atypical Case of Neuroborreliosis with Catastrophic Antiphospholipid Syndrome Ahya S. Ali, MD
02:45 PM - 03:45 PM EDT	Abstract	060 - Increased Frequency and Mortality in Persons with Neurological Disorders During COVID-19 Candace Marsters, MD
02:45 PM - 03:45 PM EDT	Abstract	061 - Tumefactive Acute Disseminated Encephalomyelitis-Like Pathology: A Rare Presentation of Q Fever Nikash Shankar, MD
02:45 PM - 03:45 PM EDT	Abstract	062 - The “Shrimp Sign” in a Case of Infratentorial PML Due to Short Telomere Syndrome Max Herman, MD
02:45 PM - 03:45 PM EDT	Abstract	063 - JC Virus Granule Cell Neuronopathy Mimicking Paraneoplastic Cerebellar Degeneration Rumyar V. Ardakani, MD
02:45 PM - 03:45 PM EDT	Abstract	064 - Rapidly Progressive HTLV-1 Associated Myelopathy after Immune Checkpoint Inhibitor Therapy Marina Buciuc, MD
02:45 PM - 03:45 PM EDT	Abstract	065 - Cryptococcal Meningitis in Immuno-competent Patient Jim Varghese, Medical Student
02:45 PM - 03:45 PM EDT	Abstract	066 - Post-infectious Inflammatory Response Syndrome after Cryptococcal Meningitis in a Patient with Sarcoidosis Marina Buciuc, MD
02:45 PM - 03:45 PM EDT	Abstract	068 - Case Report of Cerebellitis as a Rare Manifestation of HSV Encephalitis Cole M. Cimoch
02:45 PM - 03:45 PM EDT	Abstract	069 - An Uncommon Etiology of Progressive Multifocal Leuckoencephalopathy Poses Diagnostic Challenges in Sub-Saharan Africa: A Study of Six Case Series Mamadou Diallo, MD
02:45 PM - 03:45 PM EDT	Abstract	070 - Hemorrhagic Conversion of Longitudinally Extensive VZV Cervical Transverse Myelitis Avinash S. Kolli, MD
02:45 PM - 03:45 PM EDT	Abstract	071 - An Interesting Case of Rapidly Progressing Paralysis Angela Philips, MBBS, DNB, MRCP(London)
02:45 PM - 03:45 PM EDT	Abstract	072 - Nocardia Brain Abscess and Zanubrutinib Treatment for Marginal Zone Lymphoma: A Case Report Jimmy Meade
02:45 PM - 03:45 PM EDT	Abstract	073 - Granulomatous Amebic Encephalitis in a Patient Treated with Chemotherapy Marcos R. Flores Valdés, MD
02:45 PM - 03:45 PM EDT	Abstract	074 - Antiviral Therapy in the Management of Epstein-Barr Virus Encephalitis Madison Crawford
02:45 PM - 03:45 PM EDT	Abstract	075 - Dengue Hemorrhagic Encephalitis: An Uncommon Presentation of a Common Illness Shaliza Panjwani
02:45 PM - 03:45 PM EDT	Abstract	076 - Extended Spectrum Beta Lactamase Escherichia Coli Meningitis and Varicella Zoster Virus Encephalitis with Cerebral Vasculopathy and Stroke in a Patient with HIV/AIDS Sammy T. Tran, MD
02:45 PM - 03:45 PM EDT	Abstract	077 - Seminoma Resulting in Rapidly Progressive Cerebellar Syndrome with Associated Dual Positive Kelch-like Protein 11 (KLHL11) and Leucine Zipper 4 (LUZP4)–immunoglobulin G (IgG) Antibodies Jenny Linnoila, MD, PhD
02:45 PM - 03:45 PM EDT	Abstract	078 - Reactivation of Toxoplasmosis Encephalitis in HIV-Negative Patient Following Infliximab and Baricitinib Nikash Shankar, MD
02:45 PM - 03:45 PM EDT	Abstract	079 - HTLV-1-Associated Spinocerebellar Syndromes: A Case Report and Review of the Literature Emily White, MD
02:45 PM - 03:45 PM EDT	Abstract	080 - Speechless: Karius Testing in the Identification of Coxiella burnetii Infective Endocarditis Presenting with Acute Ischemic Stroke - A Case Report Michael J. Smith, MD
02:45 PM - 03:45 PM EDT	Abstract	081 - Neurosyphilis: A Great Masquerader of Acute Ischemic Stroke – A Case Report and Diagnostic Challenge Juber D. Shaikh, MD, DM (neurology)
02:45 PM - 03:45 PM EDT	Abstract	082 - Foodborne Botulism: A Case Report on Home Canning Melissa Kreutz
02:45 PM - 03:45 PM EDT	Abstract	083 - West Nile Virus Presenting as Optic Perineuritis with Complete Recovery: Light at the End of the Tunnel Matthew E. Hendry, MD
02:45 PM - 03:45 PM EDT	Abstract	084 - Q Fever, an Under-recognized and Under-diagnosed Disease: a Case Report Tommaso Agostino, Student
02:45 PM - 03:45 PM EDT	Abstract	087 - Unusual Presentation of Creutzfeldt-Jakob Disease: A Case Report of Progressive Bulbar Symptoms with Unique Imaging Findings Zabreen Tahir, MD
02:45 PM - 03:45 PM EDT	Abstract	088 - Comparing Presentations of Paraneoplastic Cerebellar Ataxias with Anti-Yo, Anti-Tr, and Anti-VGCC Antibodies: Case Series Jessica Hunter, MD
02:45 PM - 03:45 PM EDT	Abstract	090 - Unraveling the Neurological Puzzle: From Multiple Sclerosis to Neuromyelitis Optica Ahmad A. Alkabi, MD
02:45 PM - 03:45 PM EDT	Abstract	091 - Temporal and Regional Trends in Burden of Multiple Sclerosis in Pakistan: Insights from the Global Burden of Disease Study 2019 Mariam Shabih, MD
02:45 PM - 03:45 PM EDT	Abstract	092 - Assessing White Matter Structural Integrity in MS-Related Tremor Using Diffusion Tensor Imaging Juan Jimenez
02:45 PM - 03:45 PM EDT	Abstract	093 - Impact of Social Determinants of Health in Diagnosing Creutzfeldt-Jakob Disease Nathanael J. Lee, MD, PhD
02:45 PM - 03:45 PM EDT	Abstract	094 - Immune-mediated Neuropathy with Tri-sulfated Heparin Disaccharide or Fibroblast Growth Factor Receptor 3 Antibodies in Pediatric Patients: A Case Series Tim Nguyen, MD
02:45 PM - 03:45 PM EDT	Abstract	095 - Long-term Corticosteroid Treatment Patterns and Steroid-sparing Effects of Approved Treatments for Generalized Myasthenia Gravis in the United States Christopher A. Scheiner, MD, PhD
02:45 PM - 03:45 PM EDT	Abstract	096 - Long-term Efficacy and Safety of Ravulizumab, a Long-acting Terminal Complement Inhibitor, in Adults With Anti-acetylcholine Receptor Antibody-positive Generalized Myasthenia Gravis: Final Results From the Phase 3 CHAMPION MG Open-label Extension Michele Faulkner, PharmD
02:45 PM - 03:45 PM EDT	Abstract	097 - Fixed Cycle and Q2W Dosing of Intravenous Efgartigimod for gMG: Part A of ADAPT NXT Jonathan Bosold
02:45 PM - 03:45 PM EDT	Abstract	098 - Chimeric Antigen Receptor (CAR) T-cell Therapy in Neurological Disorders Ali A. Habib, MD
02:45 PM - 03:45 PM EDT	Abstract	099 - Characterization of Clinical Course, Diagnosis, Treatment, and Outcomes of Intravascular Lymphoma with Neurologic Involvement Lucas Horta, MD

Faculty Disclosures
Sudheer Kumar Reddy Segireddy, MD	Dr. Segireddy has nothing to disclose.
Renato Mantegazza, MD	Dr. Mantegazza has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Mantegazza has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Mantegazza has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx. Dr. Mantegazza has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Mantegazza has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for SERB. The institution of Dr. Mantegazza has received research support from Alpine Immune Sciences, Inc.
Emily Eichenberger	No disclosure on file
Ibrahima Sory Barry	No disclosure on file
Thomas Garton	No disclosure on file
Krishna Nalleballe, MD, FAAN	Dr. Nalleballe has nothing to disclose.
Abdul Rahman Alchaki, MD	Dr. Alchaki has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen.
Jeffrey E. Dunn, MD, FAAN	Dr. Dunn has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Dunn has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genzyme. The institution of Dr. Dunn has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Progentec Diagnostics. Dr. Dunn has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kyverna Therapeutics. Dr. Dunn has received intellectual property interests from a discovery or technology relating to health care.
Cisse Amara	No disclosure on file
Dan Carlin	No disclosure on file
Thirumalaivasan Dhasakeerthi, MBBS	Dr. Dhasakeerthi has nothing to disclose.
Byron D. Cheon, MD	Dr. Cheon has nothing to disclose.
	No disclosure on file
Safa Kaleem, MD	Dr. Kaleem has nothing to disclose.
Irene Cortese, MD	Dr. Cortese has stock in Keires, AG. Dr. Cortese has stock in Nouscom, AG. Dr. Cortese has stock in PDC*line Pharma.
Glen Frick, MD, PhD	Dr. Frick has received personal compensation for serving as an employee of AstraZeneca/Alexion Rare Disease. Dr. Frick has stock in AstraZeneca/Alexion Rare Disease.
Faraz Arshad	Mr. Arshad has nothing to disclose.
Mariam Shabih, MD	Dr. Shabih has nothing to disclose.
Brian O'Reilly	No disclosure on file
Josie Lloyd	Josie Lloyd has received personal compensation for serving as an employee of Avalere Health. Josie Lloyd has received personal compensation for serving as an employee of Inovalon.
Pieter Van Doorn, MD	The institution of Dr. Van Doorn has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. The institution of Dr. Van Doorn has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hansa. The institution of Dr. Van Doorn has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. The institution of Dr. Van Doorn has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Octapharma. The institution of Dr. Van Doorn has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Annexon. The institution of Dr. Van Doorn has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Grifols. The institution of Dr. Van Doorn has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Octapharma. The institution of Dr. Van Doorn has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Van Doorn has received publishing royalties from a publication relating to health care.
Grace Lam	No disclosure on file
Emily Woolhiser	No disclosure on file
Sakina Matcheswalla, MBBS	Dr. Matcheswalla has nothing to disclose.
Elizabeth V. Wilson, MD	Dr. Wilson has received research support from Department of Defense. Dr. Wilson has received research support from NIH/NINDS.
Ruba D. Bou-Chahine	Dr. Bou-Chahine has nothing to disclose.
Madeleine H. McLaughlin, MD	Dr. Hebert has nothing to disclose.
Suban Amatya	Suban Amatya has nothing to disclose.
Erik Hofman	Erik Hofman has received personal compensation for serving as an employee of argenx BV. Erik Hofman has stock in argenx BV.
Rula A. AlShimi	Ms. AlShimi has nothing to disclose.
Tahseen Mozaffar, MD, FAAN	Dr. Mozaffar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion Pharmaceuticals. Dr. Mozaffar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx. Dr. Mozaffar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Mozaffar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amicus. Dr. Mozaffar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Grifols. Dr. Mozaffar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Astellas Gene Therapy. Dr. Mozaffar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bayer. Dr. Mozaffar has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Mozaffar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Applied Therapeutics. The institution of Dr. Mozaffar has received research support from NIH. The institution of Dr. Mozaffar has received research support from Muscular Dystrophy Association. The institution of Dr. Mozaffar has received research support from Sanofi. The institution of Dr. Mozaffar has received research support from Argenx. The institution of Dr. Mozaffar has received research support from Amicus Therapeutics. The institution of Dr. Mozaffar has received research support from Astellas Gene Therpay. The institution of Dr. Mozaffar has received research support from Cartesian. The institution of Dr. Mozaffar has received research support from Cabaletta. Dr. Mozaffar has received personal compensation in the range of $500-$4,999 for serving as a Study Section Member with NIH.
Eszter Barabás	No disclosure on file
Jeffrey Bakal	Jeffrey Bakal has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association.
Salman Arif	No disclosure on file
Wendy G. Mitchell, MD	Dr. Mitchell has nothing to disclose.
Gwendal Lemasson, MD	Dr. Lemasson has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for ARGENX. Dr. Lemasson has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for SANOFI.
Erik V. Burton, MD	Dr. Burton has nothing to disclose.
Diego Franciotta, MD	Dr. Franciotta has nothing to disclose.
Alexander Maslov, MD	Dr. Maslov has nothing to disclose.
Paul D. Crane, MD	Dr. Crane has nothing to disclose.
Jin Nakahara, MD, PhD, FAAN	Prof. Nakahara has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Prof. Nakahara has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Mitsubishi-Tanabe. Prof. Nakahara has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Prof. Nakahara has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Chugai. Prof. Nakahara has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Novartis. Prof. Nakahara has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Prof. Nakahara has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Prof. Nakahara has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Chugai. Prof. Nakahara has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Mitsubishi-Tanabe. Prof. Nakahara has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Takeda. Prof. Nakahara has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. Prof. Nakahara has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. Prof. Nakahara has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eisai. Prof. Nakahara has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for The Japanese Society for Internal Medicine. The institution of Prof. Nakahara has received research support from Chugai. The institution of Prof. Nakahara has received research support from Japan Society for the Promotion of Science.
Yan Zhao	No disclosure on file
Zabeen K. Mahuwala, MD, FAAN	Dr. Mahuwala has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Mahuwala has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for academic CME. Dr. Mahuwala has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen Scientific affairs. Dr. Mahuwala has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for amgen. The institution of Dr. Mahuwala has received research support from UCB, . The institution of Dr. Mahuwala has received research support from Alexion . The institution of Dr. Mahuwala has received research support from argenx . The institution of Dr. Mahuwala has received research support from immunovant.
Karl Krecke	Karl Krecke has nothing to disclose.
Marcos R. Flores Valdés, MD	Dr. Flores Valdés has nothing to disclose.
Tara Brigham	No disclosure on file
Becky J. Parks, MD	Dr. Parks has received personal compensation for serving as an employee of Alexion Pharmaceuticals. An immediate family member of Dr. Parks has received personal compensation for serving as an employee of Edward P. Evans Foundation. Dr. Parks has stock in Biogen. An immediate family member of Dr. Parks has stock in Regeneron. Dr. Parks has stock in Blueprint Medicines. Dr. Parks has stock in Sanofi. An immediate family member of Dr. Parks has stock in Vertex. Dr. Parks has stock in AstraZeneca. The institution of an immediate family member of Dr. Parks has received research support from NIH/NCI. The institution of an immediate family member of Dr. Parks has received research support from Leukemia & Lymphoma Society. The institution of an immediate family member of Dr. Parks has received research support from AstraZeneca Scholar Award.
Stefan Ciurea	Stefan Ciurea has nothing to disclose.
Abdel Qader Abu-Salih, MD	Mr. Abu-Salih has nothing to disclose.
Sagar Patel	Sagar Patel has nothing to disclose.
Marina Buciuc, MD	Dr. Buciuc has nothing to disclose.
Carlos Eduardo Vervloet Sollero, MD	Dr. Vervloet Sollero has nothing to disclose.
Guilherme D. Silva, MD	Dr. SILVA has nothing to disclose.
Finlay McAlister	No disclosure on file
Naila Kausar, MD	Dr. Kausar has nothing to disclose.
Emily White, MD	Dr. White has nothing to disclose.
Surabhi A. Garg, MD	Dr. Garg has nothing to disclose.
Andreas Meisel	Andreas Meisel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Andreas Meisel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for argenx. Andreas Meisel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Adivo. Andreas Meisel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Andreas Meisel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Andreas Meisel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Andreas Meisel has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx. The institution of Andreas Meisel has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Andreas Meisel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Andreas Meisel has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alexion. Andreas Meisel has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for argenx. Andreas Meisel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. Andreas Meisel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Andreas Meisel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Andreas Meisel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Pfizer/BMS. Andreas Meisel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Boehringer. Andreas Meisel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Axunio. Andreas Meisel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Desitin. Andreas Meisel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genpharm. The institution of Andreas Meisel has received research support from Alexion. The institution of Andreas Meisel has received research support from argenx. The institution of Andreas Meisel has received research support from Octapharma. The institution of Andreas Meisel has received research support from Deutsche Myasthenie Gesellschaft. The institution of Andreas Meisel has received research support from Deutsche Forschungsgemeinschaft . The institution of Andreas Meisel has received research support from Bundesministerium für Wissenschaft und Forschung. The institution of Andreas Meisel has received research support from Leducq Foundation. The institution of Andreas Meisel has received research support from Einstein Stiftung Berlin. Andreas Meisel has received publishing royalties from a publication relating to health care. Andreas Meisel has received publishing royalties from a publication relating to health care. Andreas Meisel has a non-compensated relationship as a Chairman, Medical Advisory Board with Deutsche Myasthenie Gesellschaft that is relevant to AAN interests or activities. Andreas Meisel has a non-compensated relationship as a Chairman with Berliner Schlaganfall Gesellschaft that is relevant to AAN interests or activities.
Amanda R. Sellers, MD	Dr. Sellers has nothing to disclose.
Cole Cimoch	No disclosure on file
Channa A. Hewamadduma, MBBS, PhD, FRCP, MSc	Dr. Hewamadduma has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Hewamadduma has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ARENX. Dr. Hewamadduma has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BIOGEN. Dr. Hewamadduma has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ROCHE. The institution of Dr. Hewamadduma has received research support from Neurocare . The institution of Dr. Hewamadduma has received research support from Sheffield Charitable Trust. Dr. Hewamadduma has received personal compensation in the range of $5,000-$9,999 for serving as a Adult Expert with National Health Service England (NHSE).
Kristin M. Galetta, MD	Dr. Galetta has received personal compensation in the range of $0-$499 for serving as a Speaker with Can Do MS.
Yedatore S. Venkatesh, MD, FAAN	Dr. Venkatesh has nothing to disclose.
Sukriye Damla Kara, MD	Dr. Kara has nothing to disclose.
Poosanu Thanapornsangsuth	Poosanu Thanapornsangsuth has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai.
Russell J. Van Coevering III, MD	Dr. Van Coevering has nothing to disclose.
Harsh Nawal	Mr. Nawal has nothing to disclose.
Arshad Mujeebuddin, MBBS	Dr. Mujeebuddin has received personal compensation for serving as an employee of Alexion AstraZeneca Rare Disease. Dr. Mujeebuddin has stock in AstraZeneca.
Matthew E. Hendry, MD	Mr. Hendry has nothing to disclose.
Anette Schulz	No disclosure on file
Jon Rosenberg, MD	Dr. Rosenberg has nothing to disclose.
Patrick T. Brain, DO Student	Mr. Brain has nothing to disclose.
Sanjay Rajan	No disclosure on file
Emmanuelle Waubant, MD, PhD, FAAN	The institution of Dr. Waubant has received research support from NIH. The institution of Dr. Waubant has received research support from NMSS. The institution of Dr. Waubant has received research support from PCORI. The institution of Dr. Waubant has received research support from Race to Erase MS. The institution of Dr. Waubant has received research support from Roche. The institution of Dr. Waubant has received research support from Department of Defense. Dr. Waubant has received publishing royalties from a publication relating to health care.
Danielle Kei Pua, MD	Dr. Pua has nothing to disclose.
Christian Eggers, MD	No disclosure on file
Colleen Harris	Colleen Harris has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis Pharmceuticals. Colleen Harris has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hoffman LaRoche Canada. Colleen Harris has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono.
Shaliza Panjwani	Miss Panjwani has nothing to disclose.
Elizabeth Matthews, MD	Dr. Matthews has nothing to disclose.
Francisco Esparza, MD	Dr. Esparza has nothing to disclose.
Mariama Boubacar Diallo	Dr. Diallo has nothing to disclose.
Deborah Gelinas, MD	Dr. Gelinas has received personal compensation for serving as an employee of argenx. Dr. Gelinas has stock in argenx.
Nusrat Ahsan, MD	Dr. Ahsan has nothing to disclose.
Alfonso S. Lopez, MD	Dr. Lopez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Lopez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech .
Jennifer Creamer	No disclosure on file
Renu Pokharna, MD, FAAN	Dr. Pokharna has nothing to disclose.
Michael Barnett, MBBS	Dr. Barnett has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Clene Nanomedicine. Dr. Barnett has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Barnett has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Barnett has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Novartis. An immediate family member of Dr. Barnett has stock in Sydney Neuroimaging Analysis Centre. The institution of Dr. Barnett has received research support from BMS. Dr. Barnett has received personal compensation in the range of $500-$4,999 for serving as a Moderator/Speaker with Beamtree. Dr. Barnett has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Biogen. Dr. Barnett has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Roche. Dr. Barnett has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Novartis. Dr. Barnett has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Alexion.
Veronica Rivas	Veronica Rivas has nothing to disclose.
Zabreen Tahir, MD	Dr. Tahir has nothing to disclose.
Kelley H. Myers, PhD	Dr. Myers has nothing to disclose.
Yoan Ganev	Mr. Ganev has nothing to disclose.
Gerome B. Vallejos, MD	Mr. Vallejos has nothing to disclose.
Cynthia Crowson	Cynthia Crowson has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Rheumatology.
Carlo Pozzilli	Carlo Pozzilli has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Carlo Pozzilli has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Carlo Pozzilli has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Carlo Pozzilli has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion.
Roy Li	Roy Li has nothing to disclose.
Enrique I. Tetlalmatzi-Azuara	No disclosure on file
Rumyar V. Ardakani, MD	Dr. Ardakani has nothing to disclose.
Anza Zahid, MD, MBBS	Dr. Zahid has nothing to disclose.
Amro E. AbuShanab, MBBS	Dr. AbuShanab has nothing to disclose.
Thanakit Pongpitakmetha	Mr. Pongpitakmetha has nothing to disclose.
Ravish A. Kothari, MD	Dr. Kothari has nothing to disclose.
Kristl Claeys, MD, PhD	Dr. Claeys has nothing to disclose.
Rebecca MacRae, MD	Dr. MacRae has nothing to disclose.
Zachary T. Lazzari, MD	Dr. Lazzari has nothing to disclose.
Meraj Fatima, FCPS, FEBN	Dr. Fatima has nothing to disclose.
Danish A. Ashraf	Mr. Ashraf has nothing to disclose.
Shahram Attarian, MD, PhD	Prof. Attarian has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SANOFI, Pfizer LFB, Alnylam Biogen Argenx, UCB Alexion, Astrazenica, Amicus, Janssen, Novartis, Roche. Prof. Attarian has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for SANOFI, Biogen,Alnylam, Argenx, USB, Alexion Astrazenica, Janssen, Roche, Amgen. The institution of Prof. Attarian has received research support from National Institut of Health .
Matthew He	Matthew He has nothing to disclose.
Luis Querol, MD, PhD	Dr. Querol has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CSL Behring. The institution of Dr. Querol has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB. Dr. Querol has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for ArgenX. Dr. Querol has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Querol has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dianthus. Dr. Querol has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alnylam. Dr. Querol has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Annexon. Dr. Querol has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avilar. Dr. Querol has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biocryst. Dr. Querol has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Querol has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Querol has received personal compensation in the range of $500-$4,999 for serving as a Consultant for KPL. Dr. Querol has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lycia. The institution of Dr. Querol has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Querol has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Querol has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Querol has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. The institution of Dr. Querol has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Querol has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ArgenX. Dr. Querol has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Querol has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Dr. Querol has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Grifols. The institution of Dr. Querol has received research support from GBS-CIDP Foundation International. The institution of Dr. Querol has received research support from Grifols. The institution of Dr. Querol has received research support from ISCIII. The institution of Dr. Querol has received research support from CIBERER. The institution of Dr. Querol has received research support from UCB. The institution of Dr. Querol has received research support from ArgenX.
Renee Dreher	No disclosure on file
Gina S. Perez-Giraldo, MD	Dr. Perez-Giraldo has received personal compensation for serving as an employee of TG therapeutics. Dr. Perez-Giraldo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG therapeutics.
Celia Oreja Guevara	Celia Oreja Guevara has received personal compensation in the range of $500-$4,999 for serving as a Consultant for sanofi. Celia Oreja Guevara has received personal compensation in the range of $500-$4,999 for serving as a Consultant for roche. Celia Oreja Guevara has received personal compensation in the range of $500-$4,999 for serving as a Consultant for merck. Celia Oreja Guevara has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for merck. Celia Oreja Guevara has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for roche. Celia Oreja Guevara has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for sanofi. Celia Oreja Guevara has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for novartis. Celia Oreja Guevara has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for viatris. Celia Oreja Guevara has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for biogen. Celia Oreja Guevara has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for bms. Celia Oreja Guevara has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for jannsen.
Daniel Pastula, MD, MHS, FAAN	Dr. Pastula has nothing to disclose.
Maya S. Graham, MD	The institution of Dr. Graham has received research support from the A. James and Alice B. Clark Foundation. The institution of Dr. Graham has received research support from NINDS.
Jaahnavee Trivedi, MD	Dr. Trivedi has nothing to disclose.
Bruna Leles Vieira de Souza, MD	Miss Leles Vieira de Souza has nothing to disclose.
Thanapoom Taweephol, MD	Dr. Taweephol has nothing to disclose.
Yosra Nadhimi	Miss Nadhimi has nothing to disclose.
Melissa Taney, PhD	Dr. Taney has received personal compensation for serving as an employee of Alexion Astrazeneca Rare Disease. Dr. Taney has stock in Alexion Astrazeneca Rare Disease.
Addison Neighbors, MD	Dr. Neighbors has nothing to disclose.
Michael Herce, MD	The institution of Dr. Herce has received research support from NIH.
Rosa H. Jimenez, MD, PhD	Dr. Jimenez has nothing to disclose.
Yash Nene, MBBS	Dr. Nene has nothing to disclose.
Emma Sherfinski, MD	Dr. Sherfinski has nothing to disclose.
Sharmeela Kuperan, MD	Dr. Kuperan has nothing to disclose.
Favour C. Ononogbu-Uche	Mr. Ononogbu-Uche has nothing to disclose.
Melissa Kreutz	Ms. Kreutz has nothing to disclose.
Murray Lowe	No disclosure on file
Kelly G. Gwathmey, MD	Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion Pharmaceuticals. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Strongbridge. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Gwathmey has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion Pharmaceuticals. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cabaletta. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion Pharmaceuticals.
Thomas F. Scott, MD	Dr. Scott has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genzyme-Sanofi. Dr. Scott has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Serono. Dr. Scott has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Scott has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Genentech. Dr. Scott has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genzyme.
Souleymane Mbara Diallo	No disclosure on file
Alessandro D. Confettura	No disclosure on file
Haider Ashfaq	Haider Ashfaq has nothing to disclose.
John W. Rose, MD, FAAN	The institution of Dr. Rose has received research support from National Multiple Sclerosis Society. The institution of Dr. Rose has received research support from Guthy Jackson Charitable Foundation. The institution of Dr. Rose has received research support from NIH . The institution of Dr. Rose has received research support from VA. The institution of Dr. Rose has received research support from Biogen. The institution of Dr. Rose has received research support from Friends of MS. Dr. Rose has received intellectual property interests from a discovery or technology relating to health care.
Varun Kannan, MD	Dr. Kannan has nothing to disclose.
Nathanael J. Lee, MD, PhD	Dr. Lee has nothing to disclose.
William R. Meador, MD	Dr. Meador has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for ForensisGroup. The institution of Dr. Meador has received research support from PCORI. The institution of Dr. Meador has received research support from ROCHE/GENENTECH.
Keisha Barrera	Ms. Barrera has nothing to disclose.
Miranda Montion	Mrs. Montion has nothing to disclose.
Angela Philips, MBBS, DNB, MRCP(London)	Dr. Philips has nothing to disclose.
Eithel A. Valenzuela Mendivil	Eithel A. Valenzuela Mendivil has nothing to disclose.
Pasin Hemachudha, MBBS	Dr. Hemachudha has nothing to disclose.
Anna Babaie, DO	Dr. Babaie has nothing to disclose.
Jeannette Stankowski, PhD	Dr. Stankowski has nothing to disclose.
Daniel B. Groblewski, MD	Dr. Groblewski has nothing to disclose.
Jao Garcia	No disclosure on file
Sarah A. Morrow, MD, MSC, FRCPC, FAAN	Dr. Morrow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono/Merck. Dr. Morrow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene. Dr. Morrow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Morrow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Morrow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SanofiGenzyme. Dr. Morrow has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen Idec. Dr. Morrow has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Novartis. Dr. Morrow has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche. The institution of Dr. Morrow has received research support from Celgene. The institution of Dr. Morrow has received research support from SanofiGenzyme. The institution of Dr. Morrow has received research support from Novartis.
Alicia Johnston	No disclosure on file
Rajasingam Jayasingam	No disclosure on file
James F. Howard, Jr., MD, FAAN	Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx . Dr. Howard has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Regeneron Pharmaceuticals. Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion Pharmaceuticals. Dr. Howard has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AMGEN (Horizon Therapeutics). Dr. Howard has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Howard has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven Ltd. Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CorEvitas. Dr. Howard has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck EMD Serono. Dr. Howard has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cartesian Therapeutics. Dr. Howard has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NMD Pharma. Dr. Howard has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for H. Lundbeck A/S. Dr. Howard has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Seismic Therapeutics. Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharma. Dr. Howard has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vor Biopharma. Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Academic CME. Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for PeerView CME. Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Platform Q CME. Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for MJH LifeSci. Dr. Howard has or had stock in Johnson & Johnson dividends.Dr. Howard has or had stock in Pfizer dividends. An immediate family member of Dr. Howard has or had stock in GlaxoSmithKline dividends.Dr. Howard has or had stock in Bristol Myer Squbb dividends.Dr. Howard has or had stock in AbbieVie Inc. The institution of Dr. Howard has received research support from Alexion Pharmaceuticals. The institution of Dr. Howard has received research support from argenx . The institution of Dr. Howard has received research support from UCB Biosciences. The institution of Dr. Howard has received research support from NIH. The institution of Dr. Howard has received research support from Centers for Disease Control/Research Triangle Institute. The institution of Dr. Howard has received research support from Cartestian Therapeutics. The institution of Dr. Howard has received research support from NMD Pharma. The institution of Dr. Howard has received research support from Ad Scientiam. The institution of Dr. Howard has received research support from Merck EMD Serono. Dr. Howard has a non-compensated relationship as a Scientific Advisiory Board member, Committee member with Myasthenia Gravis Foundation of America that is relevant to AAN interests or activities. Dr. Howard has a non-compensated relationship as a Committee member with American Assoc Neuromuscular and Electrodiagnostic Medicine that is relevant to AAN interests or activities.
Hafsa Kamboh	Hafsa Kamboh has stock in Cartesian Therapeutics, Inc..
Stacey Clardy, MD, PhD, FAAN	Dr. Clardy has received personal compensation for serving as an employee of Veterans Health Administration (VHA). Dr. Clardy has received personal compensation for serving as an employee of University of Utah Health. Dr. Clardy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AstraZeneca/Alexion. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen/Horizon. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Arialys. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kyverna. Dr. Clardy has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology/AAN Publications. The institution of Dr. Clardy has received research support from NIH/NINDS. The institution of Dr. Clardy has received research support from SRNA. The institution of Dr. Clardy has received research support from Alexion/AstraZeneca. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving as a AAN Summer Meeting CoDirector Travel and Lodging with AAN. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving as a Grand Rounds Travel/Lodging/Honoraria with U of Iowa, Miami, Stanford, Barrow, Beaumont Health, CCF, Emory, Penn State, Mayo Clinic, Walter Reed.
Ho Jin Kim, MD	Dr. Kim has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Altos Biologics, AstraZeneca, Biogen, Daewoong Pharmaceutical, Kaigene, Kolon Life Science, MDimune, Roche, and Sanofi. Dr. Kim has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion, AstraZeneca, Eisai, GC Pharma, Merck, Mitsubishi Tanabe Pharma, and Roche. Dr. Kim has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Multiple Sclerosis Journal, Journal of Clinical Neurology.
Fawad Yousuf, MBBS	Dr. Yousuf has nothing to disclose.
Smriti Rajan	Smriti Rajan has nothing to disclose.
Tarun Betha	No disclosure on file
Saif Faiek	No disclosure on file
Laura Cacciaguerra, MD, PhD	Dr. Cacciaguerra has nothing to disclose.
Joshua Currie	Mr. Currie has nothing to disclose.
Muhammad Khalid, MD	Dr. Khalid has nothing to disclose.
Max Herman, MD	Dr. Herman has nothing to disclose.
Sara Achenbach	No disclosure on file
Munachiso Ngene, MPH	An immediate family member of Ms. Ngene has received personal compensation for serving as an employee of eClinicalWorks.
Samantha Plum, MD	Dr. Scoville has nothing to disclose.
Vanessa E. Chicas	Miss Chicas has nothing to disclose.
Jaya Tapadar nee Chakravarty	Jaya Chakravarty has nothing to disclose.
Ahmed A. Bayoumi, MD	Dr. Bayoumi has nothing to disclose.
Enrique Alvarez, MD, PhD	Dr. Alvarez has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Alvarez has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Alvarez has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Alvarez has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Alvarez has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Alvarez has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene/BMS. The institution of an immediate family member of Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. The institution of Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon.
Sathya S. Narasimhan, MBBS	Dr. Narasimhan has nothing to disclose.
Allyson Hamacher, PA	Ms. Hamacher has received personal compensation in the range of $500-$4,999 for serving as a Speaker with ThriveAP.
Lakshmi Chauhan, MD	The institution of Dr. Chauhan has received research support from NIH. The institution of an immediate family member of Dr. Chauhan has received research support from University of Colorado.
Kenneth L. Tyler, MD, FAAN	Dr. Tyler has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Protagonist Therapeutics, Newark CA. Dr. Tyler has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Neurological Association/Wiley. Dr. Tyler has received intellectual property interests from a discovery or technology relating to health care. Dr. Tyler has received publishing royalties from a publication relating to health care. Dr. Tyler has a non-compensated relationship as a Director (ex officio) with American Neurological association that is relevant to AAN interests or activities. Dr. Tyler has a non-compensated relationship as a Director with International Society for Neurovirology that is relevant to AAN interests or activities.
Manaswi Chaubey, MD	Dr. Chaubey has nothing to disclose.
Sammy T. Tran, MD	Dr. Tran has nothing to disclose.
Grace Gombolay, MD, FAAN	The institution of Dr. Gombolay has received research support from CDC. The institution of Dr. Gombolay has received research support from NIH.
Jacqueline Palace	Dr. Palace has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck Serono, Medimmune, Argenx, Janssen, AMgen, UCB, Roche, Novartis, Amplo, Alexion, . Dr. Palace has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx, Sanofi. Dr. Palace has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Roche, UCB, Alexion, Amgen. Dr. Palace has or had stock in Astra Zenica. The institution of Dr. Palace has received research support from Roche, AMPLO, Alexion, UCB,. argenx, amgen. Dr. Palace has received intellectual property interests from a discovery or technology relating to health care.
Yosuf Kagzi	No disclosure on file
Amy Kunchok, MBBS	Dr. Kunchok has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology:Open Access Journal .
Jeff Guptill, MD, FAAN	Dr. Guptill has received personal compensation for serving as an employee of argenx. Dr. Guptill has or had stock in argenx.
Claudiu Georgescu	No disclosure on file
Jessica T. Lin	The institution of Dr. Lin has received research support from NIH.
Samira Apostolos-Pereira	Samira Apostolos-Pereira has nothing to disclose.
Gunjanpreet Kaur, MD	Dr. Kaur has nothing to disclose.
Lindsey Przybyl	Lindsey Przybyl has received personal compensation for serving as an employee of Alexion, AstraZeneca Rare Disease. Lindsey Przybyl has stock in AstraZeneca.
Zsuzsanna Beleznay	No disclosure on file
Jeffrey L. Bennett, MD, PhD, FAAN	Dr. Bennett has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amgen. Dr. Bennett has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Bennett has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Bennett has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Mitsubishi Tanabe. Dr. Bennett has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immpact Bio. Dr. Bennett has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Chugai. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Beigene. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Imcyse. Dr. Bennett has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MIAC. Dr. Bennett has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CorEvitas. Dr. Bennett has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Alexion. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Vindico. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Touch IME. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Efficient LLC. Dr. Bennett has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Pavich. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Marie Bush. Dr. Bennett has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Marks Gray. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Knight, Nicastro, MacKay. The institution of Dr. Bennett has received research support from Alexion. The institution of Dr. Bennett has received research support from Genentech. Dr. Bennett has received intellectual property interests from a discovery or technology relating to health care. Dr. Bennett has received publishing royalties from a publication relating to health care.
Jonathan B. Parr, MD	Dr. Parr has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zymeron Corporation. The institution of Dr. Parr has received research support from Gilead Sciences.
Stephanie Gandelman, MD	Dr. Gandelman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Gandelman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen.
Alexander Carvajal- Gonzalez, MD, PhD	Dr. Carvajal- Gonzalez has nothing to disclose.
Osman Ozel, MD	Dr. Ozel has nothing to disclose.
Jon A. Cokley, PharmD	An immediate family member of Dr. Cokley has received personal compensation for serving as an employee of Johnson and Johnson Vision. Dr. Cokley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Xenon Pharmaceuticals. Dr. Cokley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Wolters Kluwer. Dr. Cokley has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB Pharmaceuticals. Dr. Cokley has received publishing royalties from a publication relating to health care. Dr. Cokley has a non-compensated relationship as a Board of Trustees with Neurocricitical Care Foundation that is relevant to AAN interests or activities.
Nikash Shankar, MD	Dr. Shankar has received personal compensation for serving as an employee of Medstar Georgetown.
Seema Arshed	Ms. Arshed has nothing to disclose.
Mattia Wruble, MD	The institution of Dr. Wruble has received research support from Alexion. The institution of Dr. Wruble has received research support from Roche.
Ankur Bhambri, MD	Dr. Bhambri has nothing to disclose.
Tommaso Agostino, Student	Tommaso Agostino has nothing to disclose.
Mahad Butt	Mahad Butt has nothing to disclose.
Gary Wormser	No disclosure on file
Jerome De Seze	Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma.
Elena Ballante	No disclosure on file
Wenzhuan He, MD	Dr. He has nothing to disclose.
Devon Conway, MD	Dr. Conway has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Conway has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Conway has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Conway has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen. Dr. Conway has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Conway has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Conway has received research support from Novartis. The institution of Dr. Conway has received research support from BMS. The institution of Dr. Conway has received research support from Biogen.
Sami Fam	Sami Fam has received personal compensation for serving as an employee of Alexion Pharmaceuticals. Sami Fam has or had stock in Astra Zeneca.
Danah Bakir, MD	Dr. Bakir has nothing to disclose.
Juber D. Shaikh, MD, DM (neurology)	Dr. Shaikh has nothing to disclose.
Marta Lipowska	No disclosure on file
Jeffrey Yu, PhD	Dr. Yu has received personal compensation for serving as an employee of Alexion. Dr. Yu has stock in AstraZeneca.
Gregory Sahagian, MD, FAAN	Dr. Sahagian has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx. Dr. Sahagian has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB Pharma. Dr. Sahagian has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. The institution of Dr. Sahagian has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. The institution of Dr. Sahagian has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharma. The institution of Dr. Sahagian has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. The institution of Dr. Sahagian has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Argenx. The institution of Dr. Sahagian has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB Pharma. Dr. Sahagian has received intellectual property interests from a discovery or technology relating to health care.
Eeshal Fatima	Mr. Fatima has nothing to disclose.
Ehtesham Khalid, MBBS	Dr. Khalid has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Khalid has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Khalid has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Takeda. Dr. Khalid has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Khalid has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astrazeneca. Dr. Khalid has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Khalid has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion.
Friedemann Paul	Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hexal. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hexal. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hoffmann-La Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol-Myers Squibb GmbH & Co. KGaA (BMS. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hexal. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon Therapeutics GmbH. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hexal. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Paul has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Paul has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Paul has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for sanofi. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche . Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for F&U Confirm. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol Myers Squibb GesmbH. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for MICE Service. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for VINDICO medical education. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Beijing Novartis. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sandoz Internation GmbH. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche Thailand. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche . Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology, Neuroimmunology&Neuroinflammation.
Satoshi Kuwabara	Satoshi Kuwabara has nothing to disclose.
Erin W. McLeod, MD	Dr. McLeod has nothing to disclose.
Dagoberto Callegaro, Sr., PhD	Dr. Callegaro has nothing to disclose.
Suwatchareeporn Rotcheewaphan, MD, PhD	Dr. Rotcheewaphan has nothing to disclose.
Saira Abbas	No disclosure on file
Catherine Lachenauer	No disclosure on file
Warren Back	No disclosure on file
Deborah Forst, MD	Dr. Forst has stock in Eli Lilly. Dr. Forst has received research support from Conquer Cancer Foundation of the American Society of Clinical Oncology. Dr. Forst has received research support from Palliative Care Research Cooperative Group. Dr. Forst has received research support from American Cancer Society Institutional Research Grant.
Kathryn Clark	No disclosure on file
Prabandh R. Buchhanolla, MBBS	Dr. Buchhanolla has nothing to disclose.
Syed H. Inam, MD	Dr. Inam has nothing to disclose.
Alexander Zygmunt, MD	The institution of Dr. Zygmunt has received research support from NS-Pharma. The institution of Dr. Zygmunt has received research support from Edgewise Therapeutics.
Safoora Fatima, MD	Safoora Fatima has nothing to disclose.
Onilia Zorio, DO	Dr. Zorio has nothing to disclose.
Ting Chang	No disclosure on file
Jim Varghese, Medical Student	Mr. Varghese has nothing to disclose.
Abhilash Thatikala, MD, MBBS, DM	Dr. Thatikala has nothing to disclose.
Ali A. Habib, MD	Dr. Habib has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Habib has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for argenx. Dr. Habib has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Habib has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB. Dr. Habib has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Habib has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech/Roche. Dr. Habib has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for NMD Pharma. Dr. Habib has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizon/ Amgen. Dr. Habib has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Grifols. Dr. Habib has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Kyverna. Dr. Habib has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Jansen/Johnson & Johnson. Dr. Habib has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMDSerono/Merck. Dr. Habib has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NIH/NINDS. Dr. Habib has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunis Biomedical. Dr. Habib has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hoffman-La Roche. Dr. Habib has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Habib has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Habib has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for argenx. Dr. Habib has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB. Dr. Habib has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Jansen/Joohnson & Johnson. The institution of Dr. Habib has received research support from Alexion. The institution of Dr. Habib has received research support from Horizon/Amgen. The institution of Dr. Habib has received research support from Immunovant. The institution of Dr. Habib has received research support from UCB. The institution of Dr. Habib has received research support from argenx. The institution of Dr. Habib has received research support from CabalettaBio. The institution of Dr. Habib has received research support from Regeneron. The institution of Dr. Habib has received research support from Arcellx. The institution of Dr. Habib has received research support from Novartis. The institution of Dr. Habib has received research support from EMDSerono/Merck. The institution of Dr. Habib has received research support from Cour Pharmaceuticals.
Abhishek Pathak, MD, MBBS, DM	Dr. Pathak has nothing to disclose.
Ahmad Mahadeen, MD	Dr. Mahadeen has nothing to disclose.
Kavita Nair, PhD, FAAN	Dr. Nair has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Meyers Squibb. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Nair has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for PhRMA Foundation. Dr. Nair has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Nair has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for MJH Lifesciences. Dr. Nair has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Anylam . Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Applied Patient Experience. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Esai. Dr. Nair has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for MHJ Life Sciences. Dr. Nair has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi-Genzyme. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for ICER. The institution of Dr. Nair has received research support from Genentech. The institution of Dr. Nair has received research support from Novartis. The institution of Dr. Nair has received research support from Genentech. The institution of Dr. Nair has received research support from Phrma Foundation. The institution of Dr. Nair has received research support from Bristol Meyers Squibb. The institution of Dr. Nair has received research support from Novartis. The institution of Dr. Nair has received research support from NINDS. The institution of Dr. Nair has received research support from Sanofi Genzyme. The institution of Dr. Nair has received research support from Kyverna Therapeutcis. Dr. Nair has a non-compensated relationship as a Board Member with Center for Improving Value in Healthcare that is relevant to AAN interests or activities.
Daniel Gonzalez, MD	Dr. Gonzalez has nothing to disclose.
Farrah J. Mateen, MD, PhD, FAAN	Dr. Mateen has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Mateen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Mateen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Mateen has received research support from Genentech. The institution of Dr. Mateen has received research support from Amgen. The institution of Dr. Mateen has received research support from TG Therapeutics. Dr. Mateen has received intellectual property interests from a discovery or technology relating to health care.
Shemonti Hasan, MD	Dr. Hasan has nothing to disclose.
J. Kent Werner, Jr., MD, PhD	Dr. Werner has received personal compensation for serving as an employee of Cogentis Therapeutics. Dr. Werner has stock in Cogentis Therapeutics. Dr. Werner has received intellectual property interests from a discovery or technology relating to health care. Dr. Werner has received intellectual property interests from a discovery or technology relating to health care. Dr. Werner has received personal compensation in the range of $100,000-$499,999 for serving as a Neurologist with United States Navy. Dr. Werner has received personal compensation in the range of $50,000-$99,999 for serving as a CEO / CoFounder with Cogentis Therapeutics.
Saher Choudhary, MD	Dr. Choudhary has nothing to disclose.
Ryo Yamasaki	Ryo Yamasaki has nothing to disclose.
Erik Lattwein	No disclosure on file
Cristina Valencia Sanchez, MD	Dr. Valencia Sanchez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG therapeutics. Dr. Valencia Sanchez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Valencia Sanchez has a non-compensated relationship as a member of the medical advisory board with The MOG Project that is relevant to AAN interests or activities.
Michael Levy, MD, PhD, FAAN	Dr. Levy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Pharma. Dr. Levy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB Pharma. Dr. Levy has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Levy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Levy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Levy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Levy has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Levy has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various law firms. The institution of Dr. Levy has received research support from National Institutes Health.
Christopher Power, MD	Dr. Power has nothing to disclose.
Yihan Zhang	No disclosure on file
Michael W. Nicolle, MD	Dr. Nicolle has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Nicolle has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Various legal firms.
Jeremy Grant	No disclosure on file
Erum Khan	No disclosure on file
Makoto Kinoshita, MD, PhD	Dr. Kinoshita has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Kinoshita has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Kinoshita has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Chugai. Dr. Kinoshita has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for CSL Behring. Dr. Kinoshita has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Daiichi Sankyo. Dr. Kinoshita has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Mitsubishi Tanabe Pharma. Dr. Kinoshita has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. The institution of Dr. Kinoshita has received research support from Grants-in-Aid for Scientific Research. The institution of Dr. Kinoshita has received research support from JST Moonshot R and D program.
Fnu Javairia	Ms. Javairia has nothing to disclose.
Kelli Money, MD, PhD	Dr. Money has nothing to disclose.
Rikki Fix	Ms. Fix has nothing to disclose.
Aimen Nadeem	Miss Nadeem has nothing to disclose.
Siddhant Arora, MD	Dr. Arora has nothing to disclose.
Rija Z. Ghazanfar, MD	Dr. Ghazanfar has nothing to disclose.
Jissmaria Karickal	Ms. Karickal has nothing to disclose.
Sun Young Chung, MD	Ms. Chung has nothing to disclose.
Thomas O'Neill	Thomas O'Neill has nothing to disclose.
Kerstin Allen	Kerstin Allen has received personal compensation for serving as an employee of Alexion, AstraZeneca Rare Disease. Kerstin Allen has stock in Alexion, AstraZeneca Rare Diseas.
Eric Engebretson	Mr. Engebretson has nothing to disclose.
Sushma R. Yerram, MD	Dr. Yerram has nothing to disclose.
Christian Wilson Turalde	No disclosure on file
Samantha Banks, MD	Dr. Banks has nothing to disclose.
Margaret M. Wilson-Murphy, MD	Dr. Wilson-Murphy has nothing to disclose.
Bart Chwalisz, MD	Dr. Chwalisz has nothing to disclose.
Richard A. Lewis, MD, FAAN	Dr. Lewis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx. Dr. Lewis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for CSL Behring. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Grifols. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Takeda. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Nuvig. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Dianthus. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Janssen. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Medscape. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Annexon. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Immunovant. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BioCryst. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NervoSave. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Annexon. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TGTX. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Boehringer-Ingleheim. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Intellia. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Cartesian. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for CME Outfitters. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PeerVision. Dr. Lewis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Up to Date. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Boehringer Ingelheim. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Intellia. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Shernoff et al. Dr. Lewis has received publishing royalties from a publication relating to health care.
Cristah Prost, MD	Dr. Prost has nothing to disclose.
Arazoo Shwany	Ms. Shwany has nothing to disclose.
Alejandra Vasquez-Castillo	No disclosure on file
Christopher A. Scheiner, MD, PhD	Dr. Scheiner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Scheiner has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion Pharmaceuticals . Dr. Scheiner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CSL Behring . Dr. Scheiner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx Pharmaceuticals. Dr. Scheiner has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Scheiner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Scheiner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jansssen. Dr. Scheiner has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for CSL Behring . Dr. Scheiner has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Alexion Pharmaceuticals . Dr. Scheiner has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. Dr. Scheiner has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen. The institution of Dr. Scheiner has received research support from Alexion Pharmaceuticals .
Amanda L. Piquet, MD, FAAN	The institution of Dr. Piquet has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech/Roche. The institution of Dr. Piquet has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. The institution of Dr. Piquet has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Kyverna . The institution of Dr. Piquet has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech/Roche. The institution of Dr. Piquet has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kyverna. The institution of Dr. Piquet has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Piquet has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Sands Anderson PC. Dr. Piquet has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Joe Jones Law Firm. Dr. Piquet has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Cortez & Associates. Dr. Piquet has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Falk Waas. The institution of Dr. Piquet has received research support from Rocky Mountain MS Center. The institution of Dr. Piquet has received research support from Roche/Genentech. The institution of Dr. Piquet has received research support from NYU. The institution of Dr. Piquet has received research support from Anokion. The institution of Dr. Piquet has received research support from UCB . The institution of Dr. Piquet has received research support from Foundation for Sarcoidosis. The institution of Dr. Piquet has received research support from Kyverna . Dr. Piquet has received publishing royalties from a publication relating to health care. Dr. Piquet has received publishing royalties from a publication relating to health care. Dr. Piquet has received personal compensation in the range of $10,000-$49,999 for serving as a Litigative Consultant with US-Dept HHS/DICP. Dr. Piquet has a non-compensated relationship as a Medical Advisory Board Member with Autoimmune Encephalitis Alliance (AEA) that is relevant to AAN interests or activities. Dr. Piquet has a non-compensated relationship as a Medical Advisory Board Member with Stiff Person Syndrome Research Foundation (SPSRF) that is relevant to AAN interests or activities.
Giacomo Greco	Giacomo Greco has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Giacomo Greco has received personal compensation in the range of $0-$499 for serving as a Consultant for Amgen. Giacomo Greco has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Giacomo Greco has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis.
Shitiz K. Sriwastava, MBBS	Dr. Sriwastava has nothing to disclose.
Jeffrey A. Allen, MD	Dr. Allen has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx. Dr. Allen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for csl behring. Dr. Allen has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Takeda. Dr. Allen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Grifols. Dr. Allen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alnylam. Dr. Allen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Allen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astra Zeneca. Dr. Allen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Johnson and Johnson. Dr. Allen has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Allen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Annexon. Dr. Allen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Immunovant. Dr. Allen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Allen has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Dianthus. Dr. Allen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CSL Behring. Dr. Allen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Annexon. Dr. Allen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. Dr. Allen has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Allen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Dianthus. Dr. Allen has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for CSL behring. Dr. Allen has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Takeda. Dr. Allen has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alnylam. Dr. Allen has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alexion. Dr. Allen has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Johnson and Johnson.
Rachel Hughes Rodriguez	No disclosure on file
Marie F. Grill, MD	Dr. Grill has nothing to disclose.
Denis T. Balaban, MD	Dr. Balaban has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Infucare. The institution of Dr. Balaban has received research support from ArgenX.
Kuldeep Yadav	No disclosure on file
Barrie L. Zerwic, MD	Dr. Schmitt has nothing to disclose.
Ramit Singla, MD	Dr. Singla has nothing to disclose.
Shawn Moore, MD	Dr. Moore has nothing to disclose.
Swayam Prakash, MD, DM, FRCP, FAAN	Dr. Prakash has nothing to disclose.
Kristin Moy	No disclosure on file
Josin James, PharmD, RPh	Dr. James has received personal compensation for serving as an employee of Alexion, AstraZeneca Rare Disease . Dr. James has stock in Alexion, AstraZeneca Rare Disease .
Gregory S. Day, MD, MSc, FAAN	Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arialys Therapeutics. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for DynaMed (EBSCO Health). Dr. Day has or had stock in ANI Pharmaceuticals. The institution of Dr. Day has received research support from National Institutes of Health / NIA. The institution of Dr. Day has received research support from National Institutes of Health / NINDS. The institution of Dr. Day has received research support from Amgen Pharmaceuticals. The institution of Dr. Day has received research support from AVID Radiopharmaceuticals. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Presenter at Annual Meeting (CME) with ��ɫ��. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Content Development (CME) with PeerView, Inc. Dr. Day has received personal compensation in the range of $5,000-$9,999 for serving as a Content Development (CME) with Continuing ��ɫ��, Inc. Dr. Day has received personal compensation in the range of $5,000-$9,999 for serving as a Content Development (CME) with Ionis Pharmaceuticals. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a ��ɫ��al Case Development + Presentation (video) with PeerDirect (P\S\L Group). Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Content Development / Presentation (non-CME) with MJH Life Sciences (NeurologyLive). Dr. Day has a non-compensated relationship as a Clinical Director with Anti-NMDA Receptor Encephalitis Foundation that is relevant to AAN interests or activities.
Megan B. Edwards, DO	Dr. Edwards has nothing to disclose.
Sean J. Pittock, MD, FAAN	Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arialys. The institution of Dr. Pittock has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. The institution of Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. The institution of Dr. Pittock has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. The institution of Dr. Pittock has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion/AstraZeneka. The institution of Dr. Pittock has received research support from NIH. Dr. Pittock has received intellectual property interests from a discovery or technology relating to health care. Dr. Pittock has received intellectual property interests from a discovery or technology relating to health care. Dr. Pittock has received publishing royalties from a publication relating to health care.
Alexandria Adamski	No disclosure on file
Achim Berthele	Achim Berthele has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Achim Berthele has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Achim Berthele has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Achim Berthele has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neuraxpharm. Achim Berthele has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Achim Berthele has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CSL Behring. Achim Berthele has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sabofi. Achim Berthele has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Achim Berthele has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Roche. Achim Berthele has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Argenx. Achim Berthele has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Achim Berthele has received publishing royalties from a publication relating to health care.
Ruham Alshiekh Nasany, MD	Dr. Alshiekh Nasany has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for J&J.
Abhinbhen W. Saraya, MD	Dr. Saraya has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for bioMérieux.
Giuseppe Lauria	Giuseppe Lauria has nothing to disclose.
Zain A. Nadeem	Mr. Nadeem has nothing to disclose.
Tarek F. Bakdash, MD	Dr. Bakdash has nothing to disclose.
Aneesha N. Usman	Miss Usman has nothing to disclose.
Mario Prado	No disclosure on file
Benjamin Cho	Benjamin Cho has nothing to disclose.
David Mendoza, MD	Dr. Mendoza has nothing to disclose.
Sean T. Kenniff, MD	Dr. Kenniff has nothing to disclose.
Jessica J. Garcia-Chan, MD	Dr. Garcia-Chan has nothing to disclose.
Serena Wong, MD	Dr. Wong has nothing to disclose.
Mamadou Diallo, MD	Dr. Diallo has nothing to disclose.
Niraja S. Suresh, MD	Dr. Suresh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Anylam . Dr. Suresh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexeion. Dr. Suresh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenex. Dr. Suresh has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Takeda . Dr. Suresh has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Pfizer.
Takahisa Mikami, MD	Dr. Mikami has nothing to disclose.
Kristen Fisher, DO	Dr. Fisher has nothing to disclose.
Anna Shah, MD	The institution of Dr. Shah has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. The institution of Dr. Shah has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. The institution of Dr. Shah has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. The institution of Dr. Shah has received research support from Rocky Mountain MS Center. The institution of Dr. Shah has received research support from Genentech/Roche. Dr. Shah has received personal compensation in the range of $500-$4,999 for serving as a ��ɫ��al Speaker with Rocky Mountain MS Center.
Spencer Hutto, MD	Dr. Hutto has nothing to disclose.
Komal Masood	No disclosure on file
Amy M. Quek, MBBS	The institution of Dr. Quek has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. The institution of Dr. Quek has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. The institution of Dr. Quek has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Astra Zeneca. The institution of Dr. Quek has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. The institution of Dr. Quek has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. The institution of Dr. Quek has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Astra Zeneca.
Jason Freedman	No disclosure on file
Enrico Marchioni	Enrico Marchioni has nothing to disclose.
Sara DelVecchio	No disclosure on file
Daniela Hristova	No disclosure on file
Benjamin Van Hoorick	Dr. Van Hoorick has received personal compensation for serving as an employee of argenx. Dr. Van Hoorick has stock in argenx.
Gowri Anil Peethambar, MBBS	Dr. Anil Peethambar has nothing to disclose.
Adam Nguyen	No disclosure on file
Kelly McNeil-Posey, RN	Mrs. McNeil-Posey has received personal compensation for serving as an employee of Alexion Pharma.
Marjan Gharagozloo	No disclosure on file
Katayoun Alikhani, MD	Dr. Alikhani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Apotex, Biogen, Bristol Myers Squibb, EMD Serono, Novartis, Roche, Sanofi Genzyme.
Stefan Sillau	Stefan Sillau has nothing to disclose.
Jude H. Charles, MD	Dr. Charles has nothing to disclose.
Thomas J. Shoemaker, MD	Dr. Shoemaker has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Shoemaker has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AMGEN. Dr. Shoemaker has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono.
Karen Fernandez	No disclosure on file
Emanuela R. Sofroni, MD	Dr. Sofroni has nothing to disclose.
Syed A. Hussain, MD	Dr. Hussain has nothing to disclose.
Rikeen Dhaduk	Rikeen Dhaduk has received personal compensation for serving as an employee of St Jude Children's Research Hospital.
Rossitza Chichkova, MD	Dr. Chichkova has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Argenx. Dr. Chichkova has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Grifols. Dr. Chichkova has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB.
Pooja Patel, DO	Dr. Patel has nothing to disclose.
Rose Kohlie	No disclosure on file
Hafsa Bareen Syeda, MBBS	Dr. Syeda has nothing to disclose.
Kurt M. Sieloff, MD	Dr. Sieloff has nothing to disclose.
Rashmi Singh, Sr., MD	Dr. Singh has nothing to disclose.
Hannah Langenfeld	No disclosure on file
Faris R. Almubaslat, MD, MPH	Dr. Almubaslat has nothing to disclose.
Ketan Thakar	No disclosure on file
Shamik Bhattacharyya, MD, FAAN	Dr. Bhattacharyya has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NeuroLambda. Dr. Bhattacharyya has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion Pharmaceuticals. Dr. Bhattacharyya has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Bhattacharyya has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Bhattacharyya has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Continuum. Dr. Bhattacharyya has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wiley. Dr. Bhattacharyya has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Merck. The institution of Dr. Bhattacharyya has received research support from Alexion Pharmaceuticals. The institution of Dr. Bhattacharyya has received research support from National Institute of Health. The institution of Dr. Bhattacharyya has received research support from UCB. The institution of Dr. Bhattacharyya has received research support from Genentech. Dr. Bhattacharyya has received publishing royalties from a publication relating to health care. Dr. Bhattacharyya has received publishing royalties from a publication relating to health care.
Lissette Orozco	No disclosure on file
Ivana Basta	Ivana Basta has nothing to disclose.
Aaron M. Carlson, MD	Dr. Carlson has received research support from Horizon Therapeutics (Amgen).
Asjad Rizvi	No disclosure on file
L D. DeWitt, MD	Dr. DeWitt has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen.
Tyson Brust, MD	Dr. Brust has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Brust has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Brust has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Brust has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono.
Tim Nguyen, MD	Dr. Nguyen has nothing to disclose.
Osman Corbali, MD	Mr. Corbali has nothing to disclose.
Tania Azad	Tania Azad has nothing to disclose.
Swetha Manne, BA, MHS	Miss Manne has nothing to disclose.
Anne Sumbul	No disclosure on file
Yasmin Mashhoon, PhD	Dr. Mashhoon has received personal compensation for serving as an employee of Alexion, AstraZeneca Rare Disease . Dr. Mashhoon has stock in AstraZeneca.
Joao Vitor Mahler, MD	Dr. Mahler has received research support from The Sumaira Foundation.
Djillali Annane, MD	Dr. Annane has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. The institution of Dr. Annane has received research support from alexion.
Andrew Wolf, MD	The institution of Dr. Wolf has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. The institution of Dr. Wolf has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. The institution of Dr. Wolf has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon. The institution of Dr. Wolf has received research support from Genentech. The institution of Dr. Wolf has received research support from Rocky Mountain MS Center. The institution of Dr. Wolf has received research support from Michael J. Fox Foundation. Dr. Wolf has received publishing royalties from a publication relating to health care.
Ulrike Kaunzner, MD	Dr. Kaunzner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Kaunzner has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Medlearning.
Juan Jimenez	Juan Jimenez has nothing to disclose.
Karuna Kusan	Karuna Kusan has nothing to disclose.
Souvik Sen, MD, MS	Dr. Sen has nothing to disclose.
Eeman Ahmad	Eeman Ahmad has nothing to disclose.
Nicole Betor	Nicole Betor has received personal compensation for serving as an employee of Avalere Health.
Peter Ulrichts	Peter Ulrichts has received personal compensation for serving as an employee of argenx. Peter Ulrichts has stock in argenx.
Justin Abbatemarco, MD	Dr. Abbatemarco has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Abbatemarco has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Abbatemarco has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech . Dr. Abbatemarco has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics, Inc.. Dr. Abbatemarco has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. The institution of Dr. Abbatemarco has received research support from Amgen.
Frank Leypoldt, MD	Frank Leypoldt, MD has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Frank Leypoldt, MD has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx. Frank Leypoldt, MD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. The institution of Frank Leypoldt, MD has received research support from German Ministry of Research BMBF.
Maitreyi Mazumdar, MD	An immediate family member of Dr. Mazumdar has received personal compensation for serving as an employee of Pfizer. An immediate family member of Dr. Mazumdar has received stock or an ownership interest from Pfizer.
Drew Weber, MD	Dr. Weber has nothing to disclose.
Delphine Masschaele, PhD	Mrs. Masschaele has received personal compensation for serving as an employee of argenx. An immediate family member of Mrs. Masschaele has received personal compensation for serving as an employee of argenx. Mrs. Masschaele has stock in argenx. An immediate family member of Mrs. Masschaele has stock in argenx.
Tina Dysgaard	Tina Dysgaard has nothing to disclose.
Christine Poulos, PhD	Ms. Poulos has nothing to disclose.
Yarden Bornovski, MD	Dr. Bornovski has nothing to disclose.
Alessandro Dinoto, MD	The institution of Dr. Dinoto has received research support from Encephalitis International . The institution of Dr. Dinoto has received research support from Autoimmune Encephalitis Alliance.
Jose J. Flores-Rivera, MD	Dr. Flores-Rivera has nothing to disclose.
Robert Wildman, MD	Dr. Wildman has nothing to disclose.
ROMIL SINGH, MD, MBBS	Dr. SINGH has nothing to disclose.
Yoav Piura, MD	Dr. Piura has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Dr. Piura has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck.
Avinash S. Kolli, MD	Dr. Kolli has nothing to disclose.
Tanuja Chitnis, MD, FAAN	Dr. Chitnis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Chitnis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche-Genentech. Dr. Chitnis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octave Biosciences. Dr. Chitnis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. The institution of Dr. Chitnis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Chitnis has received research support from Novartis. The institution of Dr. Chitnis has received research support from Sanofi. The institution of Dr. Chitnis has received research support from Octave. The institution of Dr. Chitnis has received research support from Genentech-Roche. The institution of Dr. Chitnis has received research support from Tiziana Life Sciences. The institution of Dr. Chitnis has received research support from Bristol-Myers Squibb. The institution of Dr. Chitnis has received research support from Wesley Clover.
Domingo J. Coutinho Thomas, MD	Dr. Coutinho Thomas has nothing to disclose.
Luise Zech	No disclosure on file
Shahzaib Ahmed	Shahzaib Ahmed has nothing to disclose.
Madison Crawford	Madison Crawford has nothing to disclose.
John Chen	John Chen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. John Chen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. John Chen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB.
Andres Alvarez	Mr. Alvarez has nothing to disclose.
Marc Rosenblum	No disclosure on file
Pria Anand, MD	Dr. Anand has nothing to disclose.
Jacqueline A. Nicholas, MD	Dr. Nicholas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Nicholas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Nicholas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Nicholas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squib. Dr. Nicholas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Nicholas has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Nicholas has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Greenwich Biosciences. Dr. Nicholas has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Nicholas has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Nicholas has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for EMD Serono. Dr. Nicholas has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Genentech. Dr. Nicholas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Nicholas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Vielo Bio. Dr. Nicholas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol Myers Squibb. The institution of Dr. Nicholas has received research support from Novartis. The institution of Dr. Nicholas has received research support from Biogen. The institution of Dr. Nicholas has received research support from Genentech. The institution of Dr. Nicholas has received research support from PCORI. Dr. Nicholas has a non-compensated relationship as a Physician with National MS Society that is relevant to AAN interests or activities. Dr. Nicholas has a non-compensated relationship as a Physician with Siegal Rare Neuroimmune Association that is relevant to AAN interests or activities.
Bhavya Jaya Venugopal, MD	Ms. Jaya Venugopal has nothing to disclose.
Antonio Malvaso, MD	Dr. Malvaso has nothing to disclose.
Yazmin Martinez, MD, MSc	Dr. Martinez has nothing to disclose.
Sasya Pradhan, MD	Dr. Pradhan has nothing to disclose.
Vanessa Sui, MD	Dr. Sui has nothing to disclose.
Shan Chen, MD, PhD	Dr. Chen has nothing to disclose.
Philippe-Antoine Bilodeau, MD	Dr. Bilodeau has nothing to disclose.
Dean M. Wingerchuk, MD, FAAN	Dr. Wingerchuk has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics. Dr. Wingerchuk has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Wingerchuk has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Wingerchuk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Wingerchuk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Meyer Squibb. Dr. Wingerchuk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharma. Dr. Wingerchuk has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AstraZeneca. Dr. Wingerchuk has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Wingerchuk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abcuro. Dr. Wingerchuk has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wolters Kluwers.
Caleb R. McEntire, MD	Dr. McEntire has nothing to disclose.
Michael Blackowicz, PhD	Dr. Blackowicz has received personal compensation for serving as an employee of Alexion Pharmaceuticals. Dr. Blackowicz has stock in Alexion Pharmaceuticals.
Rasha Aguzzi	Rasha Aguzzi has received personal compensation for serving as an employee of Alexion Pharmaceutical. Rasha Aguzzi has stock in AstraZeneca.
Matthew Smith	Matthew Smith has nothing to disclose.
Karin Woodman, MD	Dr. Woodman has nothing to disclose.
Andrew McKeon, MD	The institution of Dr. McKeon has received research support from National Institutes of Health. Dr. McKeon has received intellectual property interests from a discovery or technology relating to health care. Dr. McKeon has received intellectual property interests from a discovery or technology relating to health care. Dr. McKeon has received publishing royalties from a publication relating to health care.
Deeksha Barman, MBBS	Deeksha Barman has nothing to disclose.
John A. Lincoln, MD, PhD	The institution of Dr. Lincoln has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Genzyme. Dr. Lincoln has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Lincoln has received research support from Deaprtment of Defense. The institution of Dr. Lincoln has received research support from National Institutes of Health. The institution of Dr. Lincoln has received research support from EMD-Serono. Dr. Lincoln has received intellectual property interests from a discovery or technology relating to health care.
Andrea Bozoki, MD, FAAN	Dr. Bozoki has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Creative Biopeptides. Dr. Bozoki has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cognition Therapeutics. The institution of Dr. Bozoki has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AviadoBio. The institution of Dr. Bozoki has received research support from Cognition Therapeutics. The institution of Dr. Bozoki has received research support from EIP Pharma. The institution of Dr. Bozoki has received research support from Transposon Therapeutics. The institution of Dr. Bozoki has received research support from Alector .
Danny Galleguillos	No disclosure on file
Joseph Oved	No disclosure on file
Anastasia Zekeridou, MD, PhD, FAAN	The institution of Dr. Zekeridou has received research support from Roche/Genentech. Dr. Zekeridou has received intellectual property interests from a discovery or technology relating to health care. Dr. Zekeridou has received intellectual property interests from a discovery or technology relating to health care. Dr. Zekeridou has received intellectual property interests from a discovery or technology relating to health care. Dr. Zekeridou has received intellectual property interests from a discovery or technology relating to health care.
Candace Marsters, MD	Dr. Marsters has nothing to disclose.
Ichiro Nakashima, MD, PhD	Dr. Nakashima has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Nakashima has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Nakashima has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Nakashima has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Chugai. Dr. Nakashima has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alexion. Dr. Nakashima has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Nakashima has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Novartis. Dr. Nakashima has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Chugai. The institution of Dr. Nakashima has received research support from LSI Medience. The institution of Dr. Nakashima has received research support from BML.
Damlanur Kaval, MD	Dr. Kaval has nothing to disclose.
Nathan Jowett	No disclosure on file
Phillip Winters	Mr. Winters has nothing to disclose.
Wilson E. Rodriguez, MD	Dr. Rodriguez has nothing to disclose.
Ahya S. Ali, MD	Dr. Ali has nothing to disclose.
Mihaela A. Simu, MD, PhD	Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis PHarma . Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Romania. Dr. Simu has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for ABBVIE. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for ABBVIE. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for ABBVIE. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Merck. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Merck. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Merck. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for TEVA. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Sanofi Romania. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Sanofi Romania. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Ipsen . Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Bayer. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Roche. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Merck. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for ABBVIE. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for UCB. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Novartis Pharma. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Ipsen. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Johnson &Johnson. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Roche . Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Sanofi. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Sanofy Romania. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for ABBVIE. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Roche. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Sanofi Romania. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Merck. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Sanofi. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Roche. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Novartis. Dr. Simu has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Merck. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Abbvie . Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Sanofi. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Novartis. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Abbvie. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Sanofi. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Johnson&Johnson. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Sanofi. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Roche. Dr. Simu has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Simu has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Johnson & Johnson . Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Novartis. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Abbvie. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Sanofi. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Sanofi. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for UCB. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Merck. Dr. Simu has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Ewopharma A G. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Roche. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Ipsen. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Novartis. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Ipsen.
Tiffany A. Eatz, MD	Dr. Eatz has nothing to disclose.
Majid M. Haditaghi, MD	Dr. Haditaghi has nothing to disclose.
Edward Brauer	Edward Brauer has received personal compensation for serving as an employee of argenx. Edward Brauer has stock in argenx.
Celia Greenlaw, MD	Dr. Greenlaw has nothing to disclose.
Brian Chang, MD, PhD	Dr. Chang has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for MicroPort. Dr. Chang has received intellectual property interests from a discovery or technology relating to health care.
Ramez Odat	No disclosure on file
Pietro Businaro	Pietro Businaro has nothing to disclose.
Alexander J. Gill, MD, PhD	Dr. Gill has received personal compensation for serving as an employee of Novartis Pharmaceuticals Corporation. Dr. Gill has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Medical Logix, LLC. Dr. Gill has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Health Union, LLC . Dr. Gill has received research support from National Multiple Sclerosis Society. Dr. Gill has a non-compensated relationship as a President, Treasurer, and Member of Board of Directors with Autoimmune Neurology Research Consortium, Inc. that is relevant to AAN interests or activities.
Eoin P. Flanagan, MBBCh, FAAN	The institution of Dr. Flanagan has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Flanagan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Pharmacy times. The institution of Dr. Flanagan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB. The institution of Dr. Flanagan has received research support from UCB. The institution of Dr. Flanagan has received research support from Roche. The institution of Dr. Flanagan has received research support from UCB. The institution of Dr. Flanagan has received research support from Merck. The institution of Dr. Flanagan has received research support from Roche. Dr. Flanagan has received publishing royalties from a publication relating to health care. Dr. Flanagan has received publishing royalties from a publication relating to health care. Dr. Flanagan has a non-compensated relationship as a Member of medical Advisory Board with The MOG Project that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial board member with Journal of The Neurologic Sciences that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial board member with Neuroimmunology Reports that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial Board Member with Neurology, Neuroimmunology Neuroinflammation (N2) Journal that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial Board Member with Neurology that is relevant to AAN interests or activities.
Tuan H. Vu, MD	Dr. Vu has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Dianthus. Dr. Vu has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Vu has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NMD Pharma. Dr. Vu has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ARGENX. Dr. Vu has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Vu has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Vu has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen (Horizon). Dr. Vu has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Johnson & Johnson. Dr. Vu has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Alexion. Dr. Vu has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for CSL Behring. Dr. Vu has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Argenx. The institution of Dr. Vu has received research support from CSL Behring. The institution of Dr. Vu has received research support from Alexion. The institution of Dr. Vu has received research support from RA Pharma/UCB. The institution of Dr. Vu has received research support from Mass Gen Hospital/Healy Platform Study. The institution of Dr. Vu has received research support from ARGENX. The institution of Dr. Vu has received research support from Horizon/Amgen. The institution of Dr. Vu has received research support from Woolsey Pharma. The institution of Dr. Vu has received research support from CSL Behring. The institution of Dr. Vu has received research support from Cartesian Therapeutics. The institution of Dr. Vu has received research support from Janssen/Johnson & Johnson. The institution of Dr. Vu has received research support from Immunovant. The institution of Dr. Vu has received research support from Regeneron. The institution of Dr. Vu has received research support from Dianthus. The institution of Dr. Vu has received research support from COUR.
Ahmed Abbas, MD	Dr. Abbas has nothing to disclose.
Breanna Alonzo, MD	Breanna Alonzo has nothing to disclose.
Pamela Danielle Lanuza, MD	No disclosure on file
Maria Martinez-Lage, MD	The institution of Dr. Martinez-Lage has received research support from NIH.
Audrey Parent	No disclosure on file
Amy H. Sim, MD	Dr. Sim has nothing to disclose.
Priyanka A. Bhatt, MD	Dr. Bhatt has nothing to disclose.
Taylor T. Schwartz, MPH	Mr. Schwartz has received personal compensation for serving as an employee of Avalere. Mr. Schwartz has received personal compensation for serving as an employee of Inovalon. The institution of Mr. Schwartz has received research support from Life Sciences Organizations.
Emma Weiskopf, MD	Dr. Weiskopf has received personal compensation for serving as an employee of Alexion AstraZeneca Rare Disease. Dr. Weiskopf has stock in Alexion Astrazeneca Rare Disease.
Danielle Pitter, MD	Dr. Pitter has nothing to disclose.
Monica M. Diaz, MD, MS	The institution of Dr. Diaz has received research support from CorEvitas. The institution of Dr. Diaz has received research support from Novartis. The institution of Dr. Diaz has received research support from Bodford Family Transverse Myelitis Center Fund.
Ahmed Raza	Ahmed Raza has nothing to disclose.
Shruti P. Agnihotri, MD	An immediate family member of Dr. Agnihotri has stock in Pfizer. The institution of Dr. Agnihotri has received research support from Roche/ Genentech.
Jafar Kafaie, MD, PhD, FAAN	Dr. Kafaie has nothing to disclose.
Yessar M. Hussain, MD	The institution of Dr. Hussain has received research support from Alnylam Pharma.
Aimen Vanood, MD	Dr. Vanood has nothing to disclose.
Connor D. Welsh, DO	Dr. Welsh has nothing to disclose.
Masahisa Katsuno	Masahisa Katsuno has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Chugai. Masahisa Katsuno has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Masahisa Katsuno has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sumitomo Pharma. Masahisa Katsuno has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Takeda. Masahisa Katsuno has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Viatris. The institution of Masahisa Katsuno has received research support from Sumitomo Pharma. The institution of Masahisa Katsuno has received research support from Nihon Mediphysics.
Lucas Horta, MD	Dr. Horta has nothing to disclose.
Milos Miljkovic	No disclosure on file
Jia Hui Hou	No disclosure on file
Teresa V. Corona Vazquez, MD	Dr. Corona Vazquez has received research support from Consejo Nacional de Ciencia y Tecnologia.
Peter A. Calabresi, MD, FAAN	Dr. Calabresi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Calabresi has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Idorsia. An immediate family member of Dr. Calabresi has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MyMD. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Myelin Repair Foundation. The institution of Dr. Calabresi has received research support from Genentech. Dr. Calabresi has received publishing royalties from a publication relating to health care. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as a Study Section Member with NIH. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as a Grant reveiwer with Myelin Repair Foundation. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as a Speaker for CME with NYAS. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Academic CME.
Jodie Burton, MD, FAAN	Dr. Burton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Burton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Burton has received personal compensation in the range of $0-$499 for serving as a Consultant for Horizon. The institution of Dr. Burton has received research support from Roy and Joan Allen Professorship for Sight. Dr. Burton has a non-compensated relationship as a Advisor with CADTH that is relevant to AAN interests or activities. Dr. Burton has a non-compensated relationship as a Advisor with Alexion that is relevant to AAN interests or activities. Dr. Burton has a non-compensated relationship as a Advisor with Horizon that is relevant to AAN interests or activities. Dr. Burton has a non-compensated relationship as a ��ɫ��al Chair with EMD Serono that is relevant to AAN interests or activities.
Mohammad Al-Bdour	Mohammad Al-Bdour has nothing to disclose.
Fiona E. Costello, MD	Dr. Costello has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Costello has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Costello has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Costello has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Costello has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Accure Therapeutics. Dr. Costello has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for the Sumaira Foundation.
Hamza Ashraf	Hamza Ashraf has nothing to disclose.
Shubham Biyani, MBBS	Dr. Biyani has nothing to disclose.
Samir D. Ruxmohan, DO	Dr. Ruxmohan has nothing to disclose.
Tejus Bale	No disclosure on file
Binxia Yang	Binxia Yang has nothing to disclose.
Michael J. Smith, MD	Dr. Smith has nothing to disclose.
Anissa Tse	No disclosure on file
Allen Chen	No disclosure on file
Ananya Vasudhar, MBBS	Dr. Vasudhar has nothing to disclose.
Syed Y. Shah, MD	Dr. Shah has nothing to disclose.
Moain Abu Dabrh	No disclosure on file
Sani Gandhi, DO	Dr. Gandhi has nothing to disclose.
Matteo Gastaldi, MD, PhD	Dr. Gastaldi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for alexion, Roche, UCB, J&J. The institution of Dr. Gastaldi has received research support from Italian Ministry of Health, FISM, AE alliance.
Arya Harikrishna, MD	Dr. Harikrishna has nothing to disclose.
Vera Bril, MD	Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CSL. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alnylam. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Grifols. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octapharma. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Powell Mansfield. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Akcea. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ionis. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Momenta (now J&J). Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NovoNordisk. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunovant. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Bril has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Akcea. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CSL. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. The institution of Dr. Bril has received research support from UCB. The institution of Dr. Bril has received research support from Argenx. The institution of Dr. Bril has received research support from Momenta (now J&J). The institution of Dr. Bril has received research support from Immunovant. The institution of Dr. Bril has received research support from Alexion. The institution of Dr. Bril has received research support from Takeda. The institution of Dr. Bril has received research support from Grifols. The institution of Dr. Bril has received research support from CSL. The institution of Dr. Bril has received research support from Octapharma. The institution of Dr. Bril has received research support from Akcea. The institution of Dr. Bril has received research support from Ionis. The institution of Dr. Bril has received research support from Viela Bio (now Horizon). Dr. Bril has received intellectual property interests from a discovery or technology relating to health care.
Michelle Devine, MD	The institution of an immediate family member of Dr. Devine has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. The institution of an immediate family member of Dr. Devine has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Astellas. An immediate family member of Dr. Devine has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. An immediate family member of Dr. Devine has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for AAN. An immediate family member of Dr. Devine has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AGRIMS. An immediate family member of Dr. Devine has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Advances in Neurology. The institution of an immediate family member of Dr. Devine has received research support from Center of Individualized Medicine, Mayo Clinic.
Divyanshu Dubey, MD, FAAN	The institution of Dr. Dubey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. The institution of Dr. Dubey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arialys. The institution of Dr. Dubey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB . Dr. Dubey has received research support from Department of Defense . Dr. Dubey has received research support from Department of Defense . Dr. Dubey has received research support from UCB. Dr. Dubey has received research support from David J. Tomassoni ALS Research Grant Program . Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care. Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care. Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care. Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care.
Adrian Kielhorn	Adrian Kielhorn has received personal compensation for serving as an employee of Alexion. Adrian Kielhorn has stock in Alexion.
Hoor Ul Ain	Hoor Ul Ain has nothing to disclose.
Maite Sabalza	No disclosure on file
Jie Lin	No disclosure on file
Abhishek Dixit	No disclosure on file
Brooke Valdez	Brooke Valdez has nothing to disclose.
Jimmy Meade	Mr. Meade has nothing to disclose.
Elena Cortes-Vicente	Elena Cortes-Vicente has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharma. Elena Cortes-Vicente has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx. Elena Cortes-Vicente has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Elena Cortes-Vicente has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Elena Cortes-Vicente has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB Pharma. Elena Cortes-Vicente has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for argenx. Elena Cortes-Vicente has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. The institution of Elena Cortes-Vicente has received research support from UCB Pharma. The institution of Elena Cortes-Vicente has received research support from Instituto de Salud Carlos III (España).
Jawwad Salam	No disclosure on file
Ryan L. Orie, PA-C	Mr. Orie has nothing to disclose.
Jenny Linnoila, MD, PhD	Dr. Linnoila has received personal compensation in the range of $10,000-$49,999 for serving as a expert respondent on autoimmune encephalitis with U.S. government/DHHS/Vaccine Injury Compensation Program.
Jan Drappatz, MD	Dr. Drappatz has stock in Pfizer. Dr. Drappatz has stock in Vertex. Dr. Drappatz has stock in GSK. The institution of Dr. Drappatz has received research support from Servier. Dr. Drappatz has received publishing royalties from a publication relating to health care.
Leonard Appleman	Leonard Appleman has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Leonard Appleman has received research support from Astellas. The institution of Leonard Appleman has received research support from BMS. The institution of Leonard Appleman has received research support from Merck. The institution of Leonard Appleman has received research support from Exelixis. The institution of Leonard Appleman has received research support from Arvina. The institution of Leonard Appleman has received research support from Amgen. The institution of Leonard Appleman has received research support from BMS.
Jodie Maranchie	Jodie Maranchie has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Jodie Maranchie has received research support from NIH. The institution of Jodie Maranchie has received research support from Janssen. The institution of Jodie Maranchie has received research support from Merck. Jodie Maranchie has received personal compensation in the range of $500-$4,999 for serving as a Grant reviewer with CDMRP. Jodie Maranchie has received personal compensation in the range of $0-$499 for serving as a Grant Reviewer with International Kidney Cancer Association.
Valerie R. Suski, DO	Dr. Suski has nothing to disclose.
Paisith Piriyawat, MD	Dr. Piriyawat has nothing to disclose.
Zhou Yang	No disclosure on file
Naqeeya Sabuwala	No disclosure on file
Chiara Rengo	No disclosure on file
Silvia Scaranzin	Silvia Scaranzin has nothing to disclose.
Stefano Bastianello	No disclosure on file
Andromachi Scaradavou	No disclosure on file
Utsav Patel, BDS, MPH	Mr. Patel has nothing to disclose.
Cole M. Cimoch	Mr. Cimoch has nothing to disclose.
Frederick E. Lepore, MD, FAAN	No disclosure on file
Jonathan Bosold	No disclosure on file
Ashwin Achuthaprasad, MD	Dr. Achuthaprasad has nothing to disclose.
Jossy Vargas Rodriguez	No disclosure on file
Joseph Thomas	No disclosure on file
Suhrud Panchawagh, MBBS	Dr. Panchawagh has nothing to disclose.
Vinay Suresh, MBBS	Dr. Suresh has nothing to disclose.
Gregory Kurgansky, DO	Dr. Kurgansky has nothing to disclose.
Ahmad A. Alkabi, MD	Mr. Alkabi has nothing to disclose.
Gerardo M. Luna-Peralta	Mr. Luna-Peralta has nothing to disclose.
Carlos Rodrigo Q. Vicuña	Mr. Vicuña has nothing to disclose.
Alvaro Montes	Mr. Montes has nothing to disclose.
Jeffrey Mora-Arévalo	Jeffrey Mora-Arévalo has nothing to disclose.
Jeancarlo Velazco	Mr. Velazco has nothing to disclose.
Uriel S. Capcha Jimenez, Jr.	Mr. Capcha Jimenez has nothing to disclose.
Hans Baltazar	No disclosure on file
Ukwen Akpoji, PharmD	Dr. Akpoji has received personal compensation for serving as an employee of Alexion, AstraZeneca Rare Disease. Dr. Akpoji has received personal compensation for serving as an employee of Pfizer, Inc. Dr. Akpoji has stock in Alexion, AstraZeneca Rare Disease.
Michele Faulkner, PharmD	Dr. Faulkner has received personal compensation for serving as an employee of Alexion-AstraZeneca Rare Disease. Dr. Faulkner has stock in Alexion-AstraZeneca Rare Disease.
Sean Kearns, PhD	Dr. Kearns has received personal compensation for serving as an employee of Alexion.
Kian Fahimdanesh, Medical Student	Mr. Fahimdanesh has nothing to disclose.
Michelle Tsai, MD	Dr. Tsai has nothing to disclose.
Carlos Cevallos, MD	Dr. Cevallos has nothing to disclose.
Jenny J. Feng, MD	Dr. Feng has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Feng has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Feng has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Feng has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon.
Jacob White	No disclosure on file
Kaushik Gokul	Kaushik Gokul has nothing to disclose.
Adam Awad, MD	Dr. Awad has nothing to disclose.
Navreet T. Chennu, MD	Mr. Chennu has nothing to disclose.
Gabriela Mata, MD	Dr. Mata has nothing to disclose.
Jessica Hunter, MD	Dr. Hunter has nothing to disclose.
Lindsay Tetreault, MD, PhD	Dr. Tetreault has nothing to disclose.
Lauren Brandes, MD	Dr. Brandes has nothing to disclose.
Giovanna Manzano, MD	Dr. Manzano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gilead Sciences. Dr. Manzano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for InfuCare Rx.
James E. Eaton III, MD	Dr. Eaton has received personal compensation in the range of $0-$499 for serving as a Consultant for Uniqure. Dr. Eaton has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Law Practices. Dr. Eaton has received personal compensation in the range of $0-$499 for serving as a Speaker with Can Do MS.
Ilya Kister, MD, FAAN	Dr. Kister has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech-Roche. Dr. Kister has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. The institution of Dr. Kister has received research support from Genentech. The institution of Dr. Kister has received research support from Novartis. Dr. Kister has received publishing royalties from a publication relating to health care.
Allen J. Aksamit, Jr., MD, FAAN	Dr. Aksamit has nothing to disclose.
Paula Barreras, MD	Dr. Barreras has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. The institution of Dr. Barreras has received research support from Foundation for Sarcoidosis Research. The institution of Dr. Barreras has received research support from ��ɫ��.
Robert Baughman	No disclosure on file
Roberto Bomprezzi, MD, FAAN	Dr. Bomprezzi has nothing to disclose.
David B. Clifford, MD, FAAN	Dr. Clifford has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Excision BioTherapeutics. Dr. Clifford has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Seagen. Dr. Clifford has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CellEvolve. Dr. Clifford has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Wave Life Sciences. Dr. Clifford has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Clifford has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Atara Biotherapeuitics. Dr. Clifford has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva. Dr. Clifford has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Clifford has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avidity (Medpace). Dr. Clifford has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. Clifford has received publishing royalties from a publication relating to health care.
Jeffrey M. Gelfand, MD, MS, FAAN	Dr. Gelfand has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Arialys. Dr. Gelfand has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ventyx Bio. An immediate family member of Dr. Gelfand has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Headache: The Journal of Head and Face Pain. The institution of Dr. Gelfand has received research support from Genentech/Roche. The institution of Dr. Gelfand has received research support from Vigil Neurosciences. An immediate family member of Dr. Gelfand has received publishing royalties from a publication relating to health care. Dr. Gelfand has received publishing royalties from a publication relating to health care. Dr. Gelfand has received publishing royalties from a publication relating to health care. Dr. Gelfand has a non-compensated relationship as a Trial Steering Committee Chairperson and member with Roche / Genentech that is relevant to AAN interests or activities.
George K. Harrold, MD	Dr. Harrold has nothing to disclose.
Noellie M. Rivera-Torres, MD	Dr. Rivera-Torres has nothing to disclose.
Lama Abdel Wahed, MD	Dr. Abdel Wahed has received personal compensation in the range of $0-$499 for serving as a Resident Honorary Speaker with Iowa Neurological Association. Dr. Abdel Wahed has received personal compensation in the range of $0-$499 for serving as a Author with MedLink. Dr. Abdel Wahed has received personal compensation in the range of $500-$4,999 for serving as a Author with AAN Continuum. Dr. Abdel Wahed has received personal compensation in the range of $0-$499 for serving as a Invited grand round speaker with University of Maryland.
Steven R. Dunham, Jr., MD	Dr. Dunham has nothing to disclose.
Rajesh K. Gupta, MBBS	Dr. Gupta has nothing to disclose.
Brandon P. Moss, MD	An immediate family member of Dr. Moss has stock in Pfizer. The institution of Dr. Moss has received research support from Novartis. The institution of Dr. Moss has received research support from Genentech.
Rohini D. Samudralwar, MD	Dr. Samudralwar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Samudralwar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Samudralwar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Samudralwar has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Multiple Sclerosis Association of America.
Aram Zabeti, MD	Dr. Zabeti has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Zabeti has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Zabeti has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Octave. Dr. Zabeti has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Zabeti has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Biogen. Dr. Zabeti has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD-Serono. Dr. Zabeti has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Zabeti has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi-Genzyme. Dr. Zabeti has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Horizon. Dr. Zabeti has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Janssen . Dr. Zabeti has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for BMS. Dr. Zabeti has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for TG.
Nagagopal Venna, MBBS, FAAN	Dr. Venna has nothing to disclose.
Tracey Cho, MD, FAAN	Dr. Cho has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kyverna. Dr. Cho has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Delve Bio. Dr. Cho has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NIH. The institution of an immediate family member of Dr. Cho has received research support from NIH. Dr. Cho has received publishing royalties from a publication relating to health care.
Siddharama Pawate, MD	The institution of Dr. Pawate has received research support from Genentech. The institution of Dr. Pawate has received research support from Biogen.
Carlos A. Pardo-Villamizar, MD	The institution of Dr. Pardo-Villamizar has received research support from National Institutes of Health. The institution of Dr. Pardo-Villamizar has received research support from Bart McLean Fund for Neuroimmunology Research .

��ɫ����

��ɫ����

��ɫ��

��ɫ��